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ABSTRACT 
The operation of the cardiovascular system is inherently mechanical. Changes in the 
stiffness of the vascular tree have been implicated in various pathophysiologic states, and 
increased aortic stiffening with age is an acknowledged biomarker and cause of 
cardiovascular disease. However, the sources and mechanisms of vascular stiffness are 
not well understood. While the extracellular matrix is generally regarded as the major 
component, little is known regarding how contractile, differentiated vascular smooth 
muscle cells (VSMCs) contribute to blood vessel stiffness. 
In this dissertation, I employed a multi-scale approach to test the hypothesis that 
VSM focal adhesions (F As), subcellular structures linking the cortical cytoskeleton to the 
surrounding matrix, dynamically regulate the stiffness of veins and arteries. First, I 
measured cortical stiffness in VSMCs, which along with FA size, increased in response 
to contractile activation in a Src-dependent manner. To directly test the applicability of 
these results to tension and stiffness development at a higher length scale, I examined 
vascular mechanics by applying small sinusoidal stretches to vascular tissue. Agonist-
induced contraction increased tissue stress and stiffness in a Src- and FAK-dependent 
Vl 
manner. Subsequent phosphotyrosine screening and follow-up with phosphosite-specific 
antibodies confirmed the involvement of FA proteins, including F AK, Src, CAS, and 
paxillin. Taken together, these results identify the FA of the VSMC, in particular the 
F AK-Src signaling complex, as a significant regulator of vascular stiffness and stress, 
although the details of this regulation were found to differ between arteries and veins. 
To examine the role of focal adhesions in cardiovascular disease, I performed 
additional experiments in an aging model that suggest aberrant FA signaling may be an 
important component of aging induced cardiovascular disease. With the ultimate goal of 
reducing vascular stiffness by disrupting FA protein-protein interactions, I screened 
several candidate decoy peptides using a high-throughput cell-based assay. Overall, this 
work documents the FA as a regulator of vascular stiffness and a potential novel 
therapeutic target for stiffness in cardiovascular disease. 
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Chapter 1: Introduction and Background 
1.1 Introduction 
Cardiovascular disease (CVD) is a group of complex, multifactorial disorders 
whose symptoms and complications represent an enormous burden on the healthcare 
system (Go, Mozaffarian et al. 2013). The operation of the cardiovascular system in 
health and disease is inherently mechanical. However, relatively little is known of the 
mechanobiological mechanisms of this function, especially with regards to the role of 
differentiated vascular smooth muscle tissues in the body. Clinically, vascular stiffness 
has proven to be of critical importance (Greenwald 2007; Mitchell, Hwang et al. 2010); 
therefore, the goal of this dissertation is to investigate the involvement of the focal 
adhesion of the vascular smooth muscle cell in blood vessel stiffness. 
1.2 Cardiovascular Disease 
Cardiovascular disease is a group of disorders of the heart and blood vessels, 
including coronary heart disease, myocardial infarction, angina pectoris, heart failure, and 
stroke (Go, Mozaffarian et al. 2013). It is the leading cause of death worldwide, 
responsible for 17.3 million deaths globally in 2008 and an expected 25 million deaths 
per year by 2030 (Mathers and Loncar 2006; World Health Organization. 2011), and it is 
also the number one cause of death in the United States, where it is responsible for 
roughly one in three deaths, making it more lethal than cancer and chronic lower 
respiratory disease combined (Go, Mozaffarian et al. 2013). In the United States, more 
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than one in three adults have at least one form of cardiovascular disease, and this number 
is projected to grow to 40.8% by 2030 (Go, Mozaffarian et al. 2013). The direct costs of 
CVD in the United States are projected to increase two- to three-fold between 2013 and 
2030, from $320 billion to an estimated $818 billion (Go, Mozaffarian et al. 2013). 
Strikingly, if all forms of major CVD were eliminated, the average life expectancy in the 
U.S. would rise by an estimated seven years (Go, Mozaffarian et al. 2013). 
Traditional risk factors for CVD include age, gender, hypertension, cholesterol, 
tobacco smoking, alcohol consumption, family history, diet, obesity, physical activity, 
and diabetes mellitus (Go, Mozaffarian et al. 2013). Recently, a newly discovered 
independent risk factor - arterial stiffness - has attracted the attention of clinicians and 
researchers. Arterial stiffening has been shown in numerous studies to precede and 
predict for negative cardiovascular outcomes (Kaess, Rong et al. 2012). Vascular 
stiffness, both arterial and venous, is known to play an important role in cardiovascular 
physiology, but it is unclear how abnormal stiffness develops (Kaess, Rong et al. 2012). 
Since arterial stiffening is an early event in cardiovascular pathogenesis, often before the 
onset of symptoms, it represents a new avenue for inquiry that can provide clues to the 
underlying cellular and molecular mechanisms of disease and could potentially lead to 
novel therapeutic interventions to halt disease progression. 
1.3 The Vascular System Across Length Scales 
It is necessary to examine the different levels of scale (molecular, cellular, tissue, 
organ, and system), as well as the interactions between the levels, in order to attain an 
2 
integrated understanding of how structure relates to physiological or pathophysiological 
function in a biological system (Figure 1.1). In this dissertation, I employ a multi-scale 
approach that examines vascular smooth muscle at the subcellular, cellular, and tissue 
levels. Thus, the remainder of this chapter presents an overview of relevant 
cardiovascular physiology broken down by length scale, with a focus on elements that are 
important in the context of vascular stiffness. 
1.4 The Organ/System Level 
1.4.1 The Circulatory System 
The circulatory system is a single closed loop, but for simplicity it is often 
considered as two paths, the systemic and the pulmonary circulations (reviewed in (Fung 
1996; Guyton and Hall 2006)). This thesis focuses on the systemic circulation, which 
supplies the tissues of the body with oxygenated blood. The left ventricle of the heart 
pumps oxygenated blood through the successively smaller vessels of the bifurcating 
arterial tree (through the proximal, large-diameter aorta and subsequent elastic arteries, 
followed by the muscular arteries and fmally the distal arterioles), through the capillaries, 
where gas- and nutrient-exchange occur, and through the venous tree (beginning with the 
distal venules, which converge into successively larger veins, and ending with the large-
diameter vena cava, which empties into the right atrium of the heart). 
In general, the arterial side of the circulation is a high pressure, high blood 
velocity system. The arteries most proximal to the heart (the aorta, carotid, iliac, femoral, 
and brachial arteries) are considered elastic conduits. The walls of these vessels expand to 
3 
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Figure 1.1. The vascular system across length scales. An integrative approach 
considering structure and function at different biological levels of scale is necessary for 
understanding cardiovascular physiology and biomechanics in health and disease. Image 
credits, from top to bottom: (Shier, Butler et al. 1999; Mitchell 2008; Mitchell 2009; 
Vetterkind and Morgan 2012). 
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accommodate the blood ejected by the heart, and the stored elastic energy is released as 
they recoil, aiding in the propulsion of blood further down the arterial tree. The flow of 
blood through the system is impeded by the peripheral muscular arteries, which account 
for roughly 60% of the total resistance to flow. This is understood simply using 
Poiseuille's Law (resistance to flow through a tube is inversely proportional to the fourth 
power of the inner radius of the tube (Parker 2009)) in combination with the fact that 
these vessels greatly outnumber the proximal conduit arteries and are of substantially 
smaller caliber. By the time blood has reached the capillaries, the mean pressure has 
dropped substantially, and the pulse pressure (the difference between systolic and 
diastolic blood pressure) has been dampened out, allowing for relatively steady flow to 
govern exchange dynamics in these vessels. By the time the blood then enters the 
compliant venous reservoir, which contains roughly 70% of the total resting blood 
volume (Guyton and Hall2006), the pressure and blood velocity are low. 
Usually the arterial and venous sides of the circulation are considered separately, 
with the arterial system determining the resistance to flow (the afterload on the heart) and 
the venous system determining the amount of blood that returns to the heart (the venous 
return, or the preload on the heart) (Tyberg 2002; Guyton and Hall 2006; Wang, Flewitt 
et al. 2006; Mitchell 2009; Parker 2009). Such a treatment can be problematic, as both 
trees are connected in single closed loop and undoubtedly influence each other. 
Furthermore, for reasons unknown, the overwhelming majority of vascular research has 
focused on the arterial system, and consequently, significantly less is known about the 
venous side. 
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1.4.2 Pulsatile Hemodynamics 
The force generated by the heart during its contraction (systole) establishes a 
pressure gradient across the systemic circulation that drives blood flow from the left 
ventricle, through the arteries and the veins (aided by the venous contractions, i.e., the 
venous pump), to the right atrium (Guyton and Hall 2006). The nature of this flow is 
determined not only by this time-variant pressure gradient, but also by the properties of 
the blood vessel wall (and to a lesser extent blood viscosity). The morphology of the 
vessel wall, its composition, and its mechanical properties vary along the length of the 
vast vascular tree (Bohr, Somlyo et al. 1980). Accordingly, flow through this system is 
quite complex, which has led to the development of simplifying models that have had 
varying success at describing pulsatile hemodynamics (Parker 2009). To this point, the 
focus of most models developed to approximate vascular flows and pressures focus on 
the arterial circuit, with the venous tree receiving little attention in comparison (Wang, 
Flewitt et al. 2006). 
Early attempts to model the arterial circulation and relate arterial pressure to 
aortic inflow invoked the Windkessel model (Westerhof, Lankhaar et al. 2009). In its 
simplest form, this lumped parameter circuit model consists of a resistor, representing the 
resistance of the small arteries and microcirculation, and a capacitor, representing the 
compliance of the large arteries. Over time, this model has seen numerous modifications 
(e.g., (Westerhof, Elzinga et al. 1971)), as it has several shortcomings. First, the model 
assumes that changes in pressure are felt instantaneously, without delays, throughout the 
entire system. In other words, it assumes that the pulse wave velocity is infinite. As we 
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now know, this is not accurate, and propagation delays and wave reflections are readily 
measured by recording pressure waveforms at various points along the arterial tree 
(Mitchell 2009). The effects of the delays and reflections are clear upon close 
examination of the aortic pressure wave and stroke output during systole. Early during 
systole, the pulse is only influenced by local proximal aortic diameter and mechanical 
properties (aortic impedance) rather than total arterial compliance, as sufficient time has 
not yet elapsed for information about the periphery to reflect back to the proximal aorta 
(Mitchell, Tardif et al. 2001). As a consequence, aortic pressure peaks when only a 
fraction of the stroke volume has been delivered to the aorta. Once the heart receives 
feedback from distal sites, it "sees" a higher compliance and delivers the remainder of the 
stroke volume. In addition, the return of reflected waves leads to measurable 
augmentation of the aortic pressure wave later in the cardiac cycle. 
A more accurate model can be constructed by treating the arterial system as a 
distributed load using transmission line theory (Taylor 1957; Taylor 1957; Avolio 2009). 
The application of transmission line theory is appropriate because wavelengths in the 
physiological range of frequencies are short relative to the physical dimensions of the 
arterial tree. Such a model accounts for spatiotemporal variation in pressure in the arterial 
tree by taking into account transit delays, impedance mismatches between arterial 
segments, and wave reflections to more accurately describe the variable timing of arrival 
of reflected waves (Mitchell 2009). 
Together with more traditional measures of cardiovascular function (e.g., mean 
arterial pressure MAP, pulse pressure PP, and so on) (Nichols and O'Rourke), examining 
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changes that occur in the pressure and flow waveforms with age or disease can provide 
clues to the mechanisms behind the changes. While the models do not explain all of the 
features of these waveforms, they lend valuable insight and provide a nice framework for 
describing and interpreting changes in cardiovascular function. 
1.4.3 Clinical Measures of Aortic Stiffness 
As mentioned previously, aortic stiffuess is an important marker for increased 
cardiovascular risk (Kaess, Rong et al. 2012). Direct measurement of vascular stiffuess is 
an invasive procedure, but the aortic stiffening documented in the literature is actually 
observed indirectly via noninvasive clinical measures that serve as surrogates for aortic 
stiffuess. The gold standard of these measures is pulse wave velocity (PWV). Carotid-
femoral PWV (CFPWV) is determined by recording carotid and femoral waveforms and 
then dividing the transit distance by the transit time between the two sites (Mitchell 
2009). It is important to clarify that PWV is different from the velocity at which blood 
travels through the lumen; it is instead a measure of the velocity at which the pressure 
signal is conducted by the vessel wall. Another surrogate measure is aortic input 
impedance, which is computed from pressure and flow waveforms recorded in the 
proximal aorta (Avolio 2009). For noninvasive measurements of these waveforms in 
humans, flow into the aorta is approximated by flow through the left ventricular outflow 
tract, and aortic pressure is approximated with a calibrated carotid pressure waveform 
(Mitchel12009). These waveforms are transformed into the frequency domain via Fourier 
analysis (since impedance depends on frequency), and their ratio is taken to get the aortic 
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input impedance spectrum Zi, which is a function of frequency. The value of Zi at zero 
frequency is the peripheral resistance, and the average value at high frequency is the 
aortic local or characteristic impedance Zc. 
Unfortunately, these measures are very often referred to simply as "stiffness," 
which is inexact and may lead to some confusion. These values should instead be deemed 
measures of "functional" or "effective" stiffness, as stiffness (or perhaps more clearly, 
"material stiffness") is precisely defmed to be geometry-independent (Greenwald 2007). 
That being said, both aortic pulse wave velocity and characteristic impedance have the 
same (square root) dependence on Young's modulus (material stiffness) and thickness 
(Mitchell 2009). Importantly, pulse wave velocity has an inverse square root dependence 
on lumen diameter, whereas characteristic impedance is fivefold more sensitive to 
changes in diameter (Mitchell 2009). This distinction is critical for proper interpretation 
of functional stiffness measurements. 
1.4.4 Implications of Increased Vascular Stiffness for Aging and CVD 
It is thought that the increased functional stiffness of the aorta comprises changes 
in aortic wall stiffness and geometry that decrease the impedance mismatch between the 
aorta and the muscular arteries, allowing greater transmission of the pulse pressure to 
distal sites (Figure 1.2) (Mitchell 2009). This excess energy causes end-organ 
complications by damaging the microvasculature in critical high-flow, low-impedance 
9 
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Figure 1.2. Pulsatile hemodynamics, aortic stiffening, and cardiovascular disease. 
Simplified model of the arterial system with a single reflection site. In this diagram, a 
thicker wall indicates a stiffer vessel. (A) In a young, healthy individual, systolic ejection 
from the heart (represented by the bulb on the left) sends a forward traveling pressure 
wave (Pf) down the aorta, which is partially reflected (Ph) at the interface with the stiffer 
muscular arteries (due to the impedance mismatch at that site) but mostly transmitted (P1). 
(B) With age or disease, the aorta stiffens, less of P ris reflected, and more of the pulsatile 
energy is transmitted into the delicate peripheral microvessels. Image taken from 
(Mitchell 2008). 
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organs, such as the heart, brain, retina, and kidney (Klein, Klein et al. 2003; Han on, 
Haulon et al. 2005; Verhave, Fesler et al. 2005; Waldstein, Rice et al. 2008). The 
increased pressure pulsatility may also promote hypertrophy or remodeling in the 
muscular arteries, which would affect resistance to flow and the blood supply to various 
tissues (Morishita, Gibbons et al. 1994; Mitchell 2009). Changes in aortic stiffness may 
also shift the timing of return of reflected waves. Return earlier in systole could augment 
the aortic pressure in such a way as to increase the load on the heart (Mitchell, Tardif et 
al. 2001). 
Studies examining mechanisms of stiffening with age largely focused on changes 
to the extracellular matrix (e.g., calcification, matrix metalloproteinases or MMPs, 
thinning and fragmentation of elastin, advanced glycation end-products or AGEs 
(Greenwald 2007); see Chapter 5.1 for more details). For the first time recently, a study 
has shown that the stiffness of the smooth muscle cells themselves changes with age 
(Qiu, Zhu et al. 2010), a finding that suggests their role has thus far been 
underappreciated and lends additional importance to this dissertation. 
1.5 The Tissue Level 
1.5.1 Vascular Tissue Organization 
The biomechanical properties of the blood vessel wall (e.g., vascular tissue 
stiffness) depend on its material composition and organization. Vascular tissue is 
composed of cells (endothelial, vascular smooth muscle, fibroblasts), matrix (principally 
elastin and collagen), and the cell-cell and cell-extracellular matrix (ECM) connections 
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that link these components (Bohr, Somlyo et al. 1980). Blood vessels are organized into 
three layers: the intima, the media, and the adventitia. The inner intimal layer contains the 
endothelial cells, potent vasoregulatory factories that secrete compounds (e.g. , nitric 
oxide) that act to modulate smooth muscle cell tone. The media, generally the thickest 
layer, contains smooth muscle cells arranged in sheets of various orientations (e.g., in 
aorta, layered cells are principally circumferential, whereas in portal vein they are mostly 
longitudinal). The adventitia contains the fibroblasts . The layers contain different 
amounts of cellular and matrix components, and cellular and matrix composition exhibit 
marked spatial heterogeneity along the length of the vascular tree. The differences in 
structure and morphology are quite pronounced between arteries and veins. 
1.5.2 Biomechanical Behavior of Vascular Tissue 
The blood vessel wall exhibits mechanical behavior that is nonlinear, anisotropic 
(different properties in different directions), and viscoelastic (exhibiting creep, stress 
relaxation, and hysteresis), with hysteresivity that is insensitive to strain rate (Fung 
1996). In the unloaded state, the wall harbors residual stresses, and in vivo it exists in a 
pre-stretched, pre-stressed configuration (Fung 1996). Structurally, the wall exhibits 
heterogeneity from its inner to outer layer and along the entire length of the vascular tree 
(Bohr, Somlyo et al. 1980). The active cellular inhabitants of the vessel wall can modify 
its mechanical behavior on short and long time scales (Greenwald 2007). While many 
quantitative models have been proposed to characterize this complex biomechanical 
behavior, most can only describe a subset of these features (Vito and Dixon 2003). 
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Importantly, very few models even try to account for cellular behaviors, and those that 
make the attempt do so with an incomplete experimental understanding of differentiated 
vascular smooth muscle mechanobiology. This thesis aims to help close this gap in the 
current understanding. 
1.5.3 Vascular Material Stiffness vs. Functional Stiffness 
As discussed previously in Section 1.4.3, the clinical measures ofPWV and Zc are 
often imprudently referred to as "stiffness." Using the Bramwell-Hill or Moens-Korteweg 
equations, these quantities can be related mathematically to Young's modulus (the 
elasticity modulus), but they are also influenced by geometric properties of the aorta 
(Nichols and O'Rourke). For this reason, they are instead indicative of "functional (or 
effective) stiffness" (Greenwald 2007). The modulus of elasticity E is a measure of 
"material stiffness;" it is intrinsic and independent of size or geometry. For an object 
loaded in uniaxial tension, it is expressed as the ratio of the applied stress cr (change in 
force normalized to cross-sectional area) to the resultant strain E (change in length 
normalized to original length). 
In vitro methods for measuring vascular tissue stiffness employed in this paper 
include stress-strain curves and small, sinusoidal perturbation analysis (Brozovich and 
Morgan 1989). Another popular approach not featured herein is the use of a pressure or 
perfusion myograph to measure vessel distensibility or compliance (Wagenseil and 
Mecham 2009). The stress-strain approach originates in engineering, and the sinusoidal 
perturbation approach has origins in the field of muscle biology. Quasi-static stress-strain 
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curves (obtained via stretching that is slow enough that inertial effects are negligible) for 
passive vascular tissue have a nonlinear, hockey stick shape. The instantaneous slope of 
the stress-strain curve is the stiffuess at that strain. Blood vessels are highly distensible at 
low strains due to elastin straining, and much stiffer at higher strains as collagen is 
uncrimped and recruited to bear the load (Roach and Burton 1957; Clark and Glagov 
1985; Silver, Christiansen et al. 1989; Glagov, Vito et al. 1992). In the sinusoidal 
perturbation method, small periodic deformations ( < 1% strain) are employed for which 
the tissue response has negligible viscous component (as exhibited by the negligible 
phase lag between the strain input signal and the stress output signal). Importantly, unlike 
with quasi-static stress-strain curves, this stretching regime has been previously shown to 
not influence cross-bridge cycling in vascular smooth muscle tissues (Brozovich and 
Morgan 1989); therefore, sinusoidal perturbation represents a technique by which 
stiffuess can be measured without altering the system. 
In this thesis, I adopt a reductionist approach that focuses on the smooth muscle 
cells and the medial layer (the thickest layer in large arteries and veins). This allows the 
influence of smooth muscle to be isolated from the vasoregulatory effects of the 
endothelium and the structural or tethering roles of the adventitia, perivascular, and 
connective tissues (Silver, Christiansen et al. 1989; Humphrey and Na 2002). 
1.6 Cellular to Subcellular Level 
1.6.1 Smooth Muscle Cells 
Smooth muscle cells are found in the walls of hollow organs and tubes throughout 
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the body (in the vascular, gastrointestinal, genitourinary, respiratory, and ocular systems) 
where their tone is responsible for controlling organ volume and shape or pushing 
intraluminal fluids (Bohr, Somlyo et al. 1980; Guyton and Hall 2006). Smooth muscle 
contraction and relaxation are impressive phenomena, as they are slower than in other 
muscle types, require less energy and oxygen for a given amount of force produced, and 
can be sustained for long periods of time. Smooth muscle tissue exhibits remarkable 
diversity across and within the six types (e.g., the contrasting tonic and phasic behaviors 
of aortic and portal vein VSMCs, respectively). Smooth muscle contraction is initiated 
and regulated by neurotransmitters, hormones, paracrine factors, mechanical stimulation, 
or electrical stimulation, and a combination of these signals may be present at any given 
instant in vivo. Vascular smooth muscle is "single-unit" (unitary) as opposed to "multi-
unit," as cells in the vessel wall are electrically coupled through gap junctions and all 
contract simultaneously in response to stimulation. 
1.6.1.1 Vascular Smooth Muscle Cell Organization 
The cytoskeleton of the differentiated vascular smooth muscle cell in the blood 
vessel wall is traditionally thought to consist of a non-contractile cytoskeleton and a 
contractile apparatus (Figure 1.3) (Small and Gimona 1998). The non-contractile 
cytoskeleton inserts into the cytoplasmic dense bodies of the contractile apparatus and 
into the cortical focal adhesions (also known as adhesion plaques or dense plaques in 
VSMCs). The dense bodies mechanically couple the non-muscle cytoskeleton with the 
contractile cytoskeleton. Focal adhesions and dense bodies serve different cellular 
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Figure 1.3. The Small model of the smooth muscle cell cytoskeleton. The Small model 
presents a static view of the smooth muscle cytoskeleton with the following components: 
the noncontractile cytoskeleton (Csk); non-muscle actin filaments (n-m. act) that pass 
through ovoid dense bodies (db); muscle actin filaments of the contractile apparatus (m. 
act) that interact with myosin (my); cortical focal adhesions or dense plaques ( dpl); and 
caveolae ( cav). Image taken from (Small and Gimona 1998). 
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functions and, accordingly, have different protein compositions (Small and Gimona 
1998). Unlike striated skeletal or cardiac muscle, and contrary to what is suggested by the 
model in Figure 1.3, the cytoskeleton of the smooth muscle cell does not possess a 
regular, repeating organization, which is why these tissues were termed "smooth" muscle. 
It is also important to note that Figure 1.3 does not show the cortical structures 
responsible for cell-cell adhesion of smooth muscle cells. This model purports what is 
essentially a static view of these structures (Bohr, Somlyo et al. 1980); however, recent 
advances have revealed that this picture of the smooth muscle cytoskeleton is incomplete 
as the cytoskeleton, especially in the cortex, is highly plastic (Cipolla, Gokina et al. 2002; 
Opazo Saez, Zhang et al. 2004; Kim, Gallant et al. 2008). 
1.6.1.2 Smooth Muscle Contraction and Regulatory Pathways 
Smooth muscle contraction is a product of interactions between myosin and actin 
(Guyton and Hall 2006; Kim, Appel et al. 2008). Contraction is often initiated by an 
increase in cytoplasmic Ca2+, mainly via transport from the extracellular fluid across the 
cell membrane (initiated in vitro, for example, via a depolarizing physiologic saline 
solution whose NaCl has been replaced by KCl that triggers the opening of voltage-
dependent Ca2+), but also via release from intracellular stores in the sarcoplasmic 
reticulum. The Ca2+ binds to calmodulin (CaM), and the resultant Ca2+ -CaM complex 
activates myosin light chain kinase (MLCK). MLCK phosphorylates the 20-kDa myosin 
light chain (LC20) at Serl9, which increases myosin's ATPase activity, resulting in 
cross-bridge cycling. 
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There are three kinds of pathways that regulate VSM contractility (Figure 1.4) 
(Kim, Appel et al. 2008). First, there are pathways that regulate myosin's ATPase activity 
by changing the phosphorylation state of LC20. These pathways involve regulation of 
MLCK and myosin phosphatase (MP) and allow LC20 phosphorylation levels to change 
while intracellular Ca2+ concentration is held constant (a phenomenon known as Ca2+ 
sensitization). Second, there are pathways that regulate the availability of actin for 
interaction with myosin via inhibitory actin-binding proteins. Stimulation of smooth 
muscle with alpha agonists (such as norepinephrine or its chemically stable analog 
phenylephrine) initiates both myosin activation and regulation of actin availability. Third, 
there is growing evidence that the nonmuscle cytoskeleton and focal adhesions also 
regulate force generation and maintenance (Kim, Gallant et al. 2008; Zhang and Gunst 
2008). Both ofthese last two regulatory pathways can also be Ca2+ independent. 
1.6.2 Mechanotransduction 
Mechanical stimuli are known to elicit biological responses at all length scales 
(Orr, Helmke et al. 2006). A few examples at the tissue level include longitudinal 
compression promoting bone growth (Leveau and Bernhardt 1984; Robling, Castillo et 
al. 2006), hydrodynamic shear stimulating the release of nitric oxide by vascular 
endothelial cells (Ranjan, Xiao et al. 1995), and injury of the skin triggering wound 
healing (Gailit and Clark 1994). At the cellular level, physical forces and the cellular 
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Figure 1.4. Regulatory pathways governing contractility in vascular smooth muscle. 
Contractility in vascular smooth muscle is influenced by pathways that regulate myosin 
activity, actin availability, and cytoskeletal/focal adhesion remodeling. Image taken from 
(Kim, Appel et al. 2008). 
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micromechanical environment influence a diverse array of cellular behaviors, including 
extracellular matrix remodeling, migration, differentiation, proliferation, and apoptosis 
(Geiger, Spatz et al. 2009). 
The conversion of physical forces and other mechanical signals during these 
processes into biochemical responses is formally called mechanotransduction (Orr, 
Helmke et al. 2006). Cells employ a number of constructs - stress-activated ion channels, 
cell-matrix contacts, cell-cell contacts (Ingber 2006; Humphrey 2008) - whose protein 
constituents, at the molecular level, provide the mechanism for this process. Applied 
forces can influence the energy landscape of a system and induce conformational changes 
in mechanosensitive proteins, for example unfolding the protein to expose cryptic binding 
sites, and thereby initiate biochemical signaling cascades (Sawada, Tamada et al. 2006; 
Vogel 2006; del Rio, Perez-Jimenez et al. 2009), or strengthening the attachment between 
proteins engaged in a catch bond (e.g., fibronectin and a5~ 1 integrin) (Dembo, Tomey et 
al. 1988; Kong, Garcia et al. 2009). It has become clear that mechanotransduction is a 
fundamental process present in all adherent cells that is essential for maintaining tissue 
structure and function (Orr, Helmke et al. 2006). Indeed, changes in tissue stiffness are 
known to occur with many disease states (e.g., cancer, cardiovascular disease), 
suggesting that aberrant mechanotransduction could play a role in the pathogenesis and 
progression of these diseases (Ingber 2003). 
1.6.3 The Focal Adhesion 
The most studied type of cell-matrix adhesion is the focal adhesion, a structure 
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traditionally known as a dense plaque or adhesion plaque in smooth muscle tissues. In the 
focal adhesion, clusters of heterodimeric transmembrane integrins mechanically bridge 
the outside of the cell to the actin cytoskeleton via a cortical complex of proteins that 
contains upwards of 100 proteins (Figure 1.5) (Geiger, Bershadsky et al. 2001; Zaidel-
Bar, ltzkovitz et al. 2007; Zaidel-Bar, ltzkovitz et al. 2007; Puklin-Faucher and Sheetz 
2009; Geiger and Zaidel-Bar 2012). In this thesis, the term focal adhesion refers to the 
submembraneous protein plaque and its associated integrins and cortical actin. Focal 
adhesion proteins c&n be roughly classified as structural proteins (e.g., talin, vinculin) 
and/or signaling proteins (e.g., Src and FAK) (Geiger, Bershadsky et al. 2001). This 
classification proves quite useful when considering the spatiotemporally complex 
network of proteins involved in the focal adhesion, but it is obviously an 
oversimplification, with many proteins assuming both functions at one instance or 
another. Focal adhesions are capable of bidirectional mechanotransduction (both so-
called "inside-out" and "outside-in" signaling) and, in addition to their structural role, 
function as dynamic hubs where inputs to mechanosensors on one side of the cell 
membrane are integrated and responded to with a mechanical or biochemical response on 
the opposite side, which may then be sensed and feed back into this loop (Bershadsky, 
Balaban et al. 2003; Roca-Cusachs, Iskratsch et al. 2012). For instance, integrins undergo 
conformational changes, priming them for binding to the ECM, and are thereby 
"activated," either by ECM binding ("outside-in") or by binding of the integrin 
cytoplasmic tail with talin ("inside-out"), or likely by force application originating from 
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Figure 1.5. The focal adhesion. The focal adhesion is collection of proteins connecting 
the actin cytoskeleton (deep red) to the extracellular matrix via transmembrane integrins 
(orange cylinders, representing the heterodimer subunits, a and ~). This cartoon 
illustrates some of the major protein-protein interactions within the focal adhesion, based 
on data from migrating cells. Whether many of these interactions occur in the 
differentiated vascular smooth muscle cell is unknown. Proteins of interest to this thesis 
include F AK, Src ("Src FK"), vinculin ("Vin"), talin ("Tal"), paxillin ("Pax"), and CAS. 
Image taken from (Geiger, Bershadsky et al. 2001). 
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extracellular or intracellular tension (Bershadsky, Balaban et al. 2003; Roca-Cusachs, 
Iskratsch et al. 2012). 
Non-migrating differentiated smooth muscle cells have long been known to 
possess focal adhesions (aka dense plaques or adhesion plaques), but these plaques were 
thought to be relatively static until recently when several studies, especially in airway 
smooth muscle, demonstrated protein translocation to adhesion plaques and to the cortical 
cytoskeleton with contractile stimulation or stretch (Somlyo 1980; Gunst and Zhang 
2008; Zhang and Gunst 2008). For this reason, almost all of what is known about focal 
adhesions comes from studies of migrating cells. Despite the difference in function 
between focal adhesions in migrating cells and in non-motile, contractile VSMCs, these 
structures have similar protein compositions (Small and Gimona 1998; Geiger, 
Bershadsky et al. 2001 ). Furthermore, contractile stimulation has been shown to induce 
phosphorylation events and changes in composition of these structures (Tang, Wu et al. 
2002; Saez, Zhang et al. 2004). 
1.6.3.1 Focal Adhesion Signaling and Dynamics in Migrating Cultured Cells 
In motile cells, focal adhesions undergo dynamic, tension-mediated growth and 
maturation (Wolfenson, Henis et al. 2009) that can be broken up into three steps: 
formation; growth and maturation; and release and recycling (Figure 1.6). 
Initially, actin polymerization at the migrating cell's leading edge (lamellipodium) 
generates a membrane protrusion (filopodium), and the integrins in this protrusion bind to 
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Figure 1.6. Focal adhesion turnover in migrating cells. Nascent adhesions, or focal 
complexes, form at the leading edge of the cell and grow into focal adhesions, traveling 
rearward as the cell advances. These focal adhesions are dissolved once they reach the 
trailing edge of the cell and then recycled for the formation of new adhesions at lamella. 
Imaged modified from (Broussard, Webb et al. 2008). 
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extracellular matrix molecules (e.g., fibronectin, collagen, laminin) (Zaidel-Bar, 
Ballestrem et al. 2003). Talin links the ECM-bound integrins to the cortical actin 
cytoskeleton, and this mechanical connection is stabilized by vinculin (Zhang, Jiang et al. 
2008; del Rio, Perez-Jimenez et al. 2009). Binding of integrin molecules to ECM induces 
integrin clustering at the site of the adhesion (Hynes 2003). 
At this point, the sub-micron, nascent focal complex either disappears or 
elongates centripetally, growing into a mature focal adhesion. This maturation process 
involves various signaling molecules, which recruit additional cytoplasmic proteins to the 
adhesion site and initiate cascades, and it also involves structural molecules (e.g., zyxin, a 
marker of mature focal adhesions that is never present in nascent focal adhesions (Zaidel-
Bar, Ballestrem et al. 2003)). As the focal adhesion matures, an actin stress fiber is 
nucleated at the site, generating a traction force across it (Zaidel-Bar, Cohen et al. 2004). 
Focal adhesion maturation has been demonstrated to be tension dependent 
(Galbraith, Yamada et al. 2002). Focal adhesions experience tensile forces originating 
from the migration along the substrate and from intracellular myosin II-based 
contractions. Throughout the focal adhesion growth cycle, protein modification via 
tyrosine phosphorylation of focal adhesion proteins modulates focal adhesion siZe, 
location, and composition (Zaidel-Bar, Cohen et al. 2004). 
As the cell moves forward, the mature focal adhesions move closer to the trailing 
edge of the cell, and their function transitions from propulsion to more of an anchorage 
role (Lauffenburger and Horwitz 1996; Beningo, Dembo et al. 2001). At the trailing 
edge, they completely dissolve and detach, and their components are recycled into the 
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cytoplasm for the formation of new focal adhesions at the cell's leading edge. Tyrosine 
phosphorylation is important during all steps of this process, as it determines the 
activation states of many focal adhesion proteins, as well as their association or 
dissociation with the focal adhesion, and it influences interactions between focal adhesion 
proteins (Fincham and Frame 1998; Webb, Donais et al. 2004; Mitra, Hanson et al. 
2005). For these reasons, tyrosine phosphorylation can be considered the biochemical 
signature of focal adhesion turnover and recycling; therefore, special attention is paid in 
this thesis to this form of post-translational modification. 
It is important to note that most migration studies examine cells moving on flat 
substrates. The behavior of focal adhesions under these circumstances differs markedly 
from their behavior in three-dimensional environments (Cukierman, Pankov et al. 2001 ). 
Additionally, focal adhesions in migrating cells exhibit obvious cycling behavior (focal 
adhesions completely tum over as their components are recycled) that contrasts with the 
more subtle changes that occur to focal adhesions in non-migrating dVSMCs in the blood 
vessel wall (Poythress, Gallant et al. 2013). Although the focal adhesion protein recycling 
that occurs in dVSMCs is not well understood, the dynamics of focal adhesion 
translocation and recycling in migrating cells may hint at focal adhesion protein functions 
in the less-studied non-motile, contractile smooth muscle phenotype. 
1.6.3.2 
1.6.3.2.1 
Focal Adhesion Protein Signaling in Migrating Cells 
FAK and Src 
FAK and Src pathways are illustrated in Figure 1.7. Focal adhesion kinase (FAK, 
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125 kDa) is an essential non-receptor tyrosine kinase that contains a FERM domain, a 
kinase domain, and a focal adhesion-targeting (FAT) domain, which recruits FAK to 
focal adhesions by associating with focal adhesion proteins such as talin and paxillin 
(Schlaepfer, Mitra et al. 2004). FAK Y397 is auto-phosphorylated upon integrin 
engagement and integrin clustering (Toutant, Costa et al. 2002; Mitra, Hanson et al. 
2005). This activates F AK and creates a high affinity-binding site for the Src-homology 
SH2 domain found in Src family kinases (SFKs) (Schaller 2001; Hanks, Ryzhova et al. 
2003; Parsons 2003; Schlaepfer, Mitra et al. 2004). 
Src (60 kDa) is recruited to this binding site (Schlaepfer, Mitra et al. 2004), and 
the resultant FAK-Src complex facilitates SH3-mediated binding of p130Cas (Crk-
associated substrate, 130 kDa) to FAK and subsequent CAS phosphorylation 
(Chodniewicz and Klemke 2004; Lim 2004; Lim, Han et al. 2004). Mechanical extension 
of CAS enhances the susceptibility of its substrate domain (CasSD) to tyrosine 
phosphorylation by SFKs (Sawada, Tamada et al. 2006). This domain has multiple 
tyrosine phosphorylation sites, one of which is Y165. Once phosphorylated, CasSD 
serves as a docking site for other SH2-containing effectors, including adaptor proteins of 
the Crk family (Chodniewicz and Klemke 2004). Binding ofCrk family members to CAS 
leads to the activation of Rae, a Rho family GTPase (Cho and Klemke 2002). 
Src-mediated phosphorylation ofF AK Y925 downstream creates an SH2 binding 
site for the growth-factor-receptor-bound protein 2 (GRB2) adaptor protein, which results 
in Ras activation (Schlaepfer, Mitra et al. 2004). Subsequent downstream activation of 
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Figure 1.7. FAK-Src signaling pathways. Autophosphorylation of FAK at Y397 upon 
integrin engagement recruits Src, which leads to phosphorylation of F AK at Y925, 
tyrosine phosphorylation of CAS and paxillin, and additional signaling cascades. Image 
taken from (Mitra, Hanson et al. 2005). 
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the ERK signaling pathway results in the phosphorylation and activation of myosin light 
chain kinase (MLCK) (Ridley, Schwartz et al. 2003; Schlaepfer, Mitra et al. 2004), which 
leads to increased contractility. F AK Y925 phosphorylation is also suspected to be 
involved in the release ofF AK from the focal adhesion (Katz, Romer et al. 2003; Mitra, 
Hanson et al. 2005). Src activation figures prominently in F AK activity. Phosphorylation 
of Src at Y416 is believed to activate the kinase, while phosphorylation at Y527 is 
believed to inactivate the kinase (Roskoski 2005). It is also believed that Src, with or 
without the aid of FAK, promotes focal adhesion turnover (Hsia, Mitra et al. 2003; 
Moissoglu and Gelman 2003; Mitra, Hanson et al. 2005). 
1.6.3.2.2 Vinculin and Meta-vinculin 
Vinculin (117 kDa, 1066 amino acids), a structural component of focal adhesions 
that controls focal adhesion formation by direct interactions with talin and actin, has three 
major domains: anN-terminal head, a flexible proline-rich hinge (neck) region, and a C-
terminal tail domain (Figure 1.8) (Eimer, Niermann et al. 1993; Winkler, Lunsdorf et al. 
1996; Humphries, Wang et al. 2007). Vinculin is located in the cytoplasm when inactive, 
i.e., when all its binding and phosphorylation sites are masked by the binding of 
vinculin's head to its tail domain (Bakolitsa, Cohen et al. 2004; Zhang, Izaguirre et al. 
2004; Chen, Cohen et al. 2005; Ziegler, Liddington et al. 2006). When recruited to the 
focal adhesion, vinculin is in an open, active confirmation, allowing talin to and actin to 
interact with its head and tail domains, respectively (Zamir and Geiger 2001; Ziegler, 
Liddington et al. 2006). Association of talin with vinculin results in integrin clustering 
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Figure 1.8. Domains and binding partners of talin and vinculin. (A) Talin directly 
links B1 integrin to actin. Talin has 11 vinculin binding sites. VBS1 , VBS2, and VBS3 are 
at residues 4, 12, and 45, respectively; the remaining binding sites are cryptic. Image 
taken from (Critchley 2009) (B) Vinculin crosslinks talin to additional actin. Image taken 
from (Mierke 2009). 
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and focal adhesion enlargement (Humphries, Wang et al. 2007). 
The mechanism of vinculin activation is unclear, as are the roles of its tyrosine 
phosphorylation sites. Y100, Y822, and Yl065 have been shown to play important roles 
in vinculin activation, stabilization, and ligand binding (Subauste, Pertz et al. 2004; 
Zhang, Izaguirre et al. 2004). In one model in the literature, it is suggested that 
phosphorylation at Y1065 regulates vinculin exchange dynamics for forming or adapting 
focal adhesions (Mohl, Kirchgessner et al. 2009). 
Meta-vinculin (134 kDa), a splice variant containing a short insert of 69 amino 
acids in the tail domain, co-expresses with vinculin in smooth muscle tissue (Gimona, 
Small et al. 1988; Byrne, Kaczorowski et al. 1992). Whereas there is a growing literature 
on vinculin, much less is known about meta-vinculin. This is because vinculin is 
constitutively expressed in many cell types, but meta-vinculin has only been found in 
muscle (Feramisco, Smart et al. 1982; Saga, Hamaguchi et al. 1985; Gimona, Furst et al. 
1987). 
1.6.3.2.3 Talin 
Talin (215 kDa) consists of a globular head containing a FERM 
( 4.1/ezrin/radixin/moesin) domain that binds to and activates ~-integrin cytodomains 
(Calderwood, Tai et al. 2004), and a rod domain that binds actin and contains up to 11 
vinculin binding sites (VBSs), many of them buried (Figure 1.8) (Papagrigoriou, Gingras 
et al. 2004; Fillingham, Gingras et al. 2005; Gingras, Ziegler et al. 2005). It has been 
shown that mechanically stretching talin exposes these cryptic VBSs (del Rio, Perez-
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Jimenez et al. 2009). Since vinculin can also bind to actin, it is supposed that additional 
crosslinking of actin to talin via vinculin represents a mechanism for reinforcing a 
strained focal adhesion (Pasapera, Schneider et al. 201 0). Tal in appears to be unique 
among proteins that link integrins with the actin cytoskeleton because it induces a 
conformational change in integrins that increases the affinity of the extracellular domain 
for ligand (Calderwood, Zent et al. 1999; Calderwood, Yan et al. 2002; Critchley 2009; 
Moser, Legate et al. 2009). The talin head is responsible for increasing integrin affinity 
for ligand, but full-length talin is required to cluster integrins into focal adhesions 
(Legate, Wickstrom et al. 2009). 
1.6.4 The Contractile vs. Synthetic Phenotype 
There are two types of smooth muscle cells found in vivo (Figure 1.9): 1) long, 
spindle-shaped, non-proliferating, non-migrating contractile cells, and 2) rounder, more 
spread out, proliferating, migrating, synthetic cells (Rensen, Doevendans et al. 2007). 
The synthetic phenotype exhibits downregulation of contractile proteins (e.g., a-smooth 
muscle actin, h-caldesmon) and loss of contractility. This synthetic phenotype has been 
implicated in embryogenesis and angiogenesis, as well as hypertension and 
atherosclerosis, and it is capable of secreting matrix and matrix degrading enzymes 
(Nishimura, Bi et al. 2006; House, Potier et al. 2008; Beamish, He et al. 2010; Wang, 
Monticone et al. 2010). Most of the smooth muscle cells in the vasculature are the 
contractile phenotype, and it is well known that the process of culturing these cells de-
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Figure 1.9. Synthetic versus contractile phenotype of VSMCs. Healthy VSMCs native 
to the vascular wall (right) exhibit spindle-shaped morphology and contractile behavior. 
Upon culturing, or in various cardiovascular diseases, these VSMCs de-differentiate, 
losing their contractility and becoming proliferative and synthetic (left). Image taken 
from (Rensen, Doevendans et al. 2007). 
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differentiates them to the synthetic phenotype (Gimona, Herzog et al. 1990; 
Bochatonpiallat, Gabbiani et al. 1992; vanEys, Voller et al. 1997; Rensen, Doevendans et 
al. 2007). For this reason, efforts were made to use the more physiologically-relevant, 
freshly-isolated differentiated smooth muscle cell model rather than the cultured cell 
model when appropriate. 
1.7 Model Systems for Studying the Cardiovascular System 
1.7.1 A7r5 Cultured Vascular Smooth Muscle Cells 
A 7r5s are embryonic, thoracic aorta-derived vascular smooth muscle cells 
originally derived from the DBlX rat (Rattus norvegicus). These cells proliferate as 
myoblasts, but they can be triggered to differentiate into a phenotype that resembles adult 
smooth muscle cells (non-proliferating, non-migrating) when they are confluent by 
complete serum starvation for 24 hours (Kimes and Brandt 1976; Firulli, Han et al. 
1998). A 7r5 VSMCs express many key markers of smooth muscle, including smooth 
muscle a-actin, smooth muscle myosin, smooth muscle tropomyosin isoforms, h1 
calponin, and SM22 a (Gimona, Kaverina et al. 2003). 
Although the A 7r5 model system bears resemblance to real contractile VSMCs, 
A 7r5s are still cultured cells and, even with serum starvation, exhibit a blend of the 
synthetic and contractile phenotypes (Rensen, Doevendans et al. 2007). That being said, 
they are easy to grow and maintain, are inexpensive compared to primary cells or freshly-
isolated cells, and are highly adherent to glass coverslips. These characteristics make 
them ideal for magnetic tweezers experiments where pulling forces are applied to these 
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cells in order to examme aortic cell mechanical properties. Additionally, they are 
preferred in this thesis over primary cells because they exhibit a more stable phenotype. 
For studies of venous VSMC mechanical properties, cells freshly-isolated by enzymatic 
digestions were employed. Freshly-isolated cells have not been out of their native 
environment for sufficient time to de-differentiate and consequently are highly contractile 
(capable of substantial shortening up to ~ 70% of initial length when stimulated to 
contract (Vetterkind and Morgan 2012)) and are most comparable to the VSMCs 
embedded in the vascular wall. 
1.7.2 Mouse 
The C57bl/6 inbred strain of lab mouse (Mus musculus) is the most widely used 
rodent strain. The C57bl/6J examined in this thesis is the most commonly used substrain. 
This mouse is excellent for studies of vascular physiology and disease because it 
develops cardiovascular disease (e.g., atherosclerosis, hypertension) and, like humans, 
exhibits increased pulse wave velocity with age, a marker for aortic stiffening (Hartley, 
Taffet et al. 1997; Wang, Halks-Miller et al. 2000). This small rodent is an excellent 
aging model because it exhibits accelerated aging in comparison to larger animal models 
(a 3 month old mouse is roughly equivalent to a 25 year old human, and a 29 month old 
mouse is roughly equivalent to a 75 year old human) (Flurkey, Currer et al. 2007). 
Additionally, these mice are easy to handle (small and docile), inexpensive, and can be 
examined with an extensive array of commercially available immunological agents. Its 
widespread use for cardiovascular and aging research means that much is known about 
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this system, and discoveries can be compared with those made by other scientists. 
Finally, genome of the J mouse is completely characterized and highly amenable to 
manipulation (Faraci and Sigmund 1999). Thus, future studies (beyond the scope of this 
thesis) employing genetic techniques can tailor this model for the specific study of a 
particular pathway involved in vascular physiology or disease. In this thesis, because of 
the advantages the mouse as a model of aging and for consistency, aorta studies are 
exclusively in rodent animal models, with tissue samples from the mouse used for 
stiffness measurements and biochemical analysis. 
1.7.3 Ferret 
Ferrets (Mus tela putorius furo) more closely resemble humans than other 
common animal models, including rodents (Cavagna, Menotti et al. 2000). Consequently, 
studies in ferrets are arguably more relevant to human physiology than studies in mice or 
rats, making the ferret the animal model of choice for a range of human diseases (e.g., 
SARS, influenza) (Roberts and Subbarao 2006; Barnard 2009). Due to ferret homology 
with humans, ferret tissue almost always cross-reacts with antibodies and other reagents 
developed for human tissue. Our lab has compiled an extensive database on ferret smooth 
muscle signaling pathways (Jiang and Morgan 1989; Khalil, Menice et al. 1995; Parker, 
Takahashi et al. 1998; Kim, Je et al. 2000; Shin, Je et al. 2002; Gangopadhyay, Takizawa 
et al. 2004; Je, Gallant et al. 2004; Marganski, Gangopadhyay et al. 2005; Kim, Gallant et 
al. 2008; Kim, Graceffa et al. 2010; Min, Reznichenko et al. 2012) that lends context to 
any discoveries made in this tissue. Practically speaking, ferret vessels provide 
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substantially more tissue mass than rodent models, which facilitates various experimental 
protocols, including enzymatic cell dissociation and protein analyses, but at greater cost 
than smaller animal models. Herein, venous studies involving tissues or cells are 
exclusively from the ferret. 
1.8 Project Aims and Impact 
Vascular stiffuess plays important roles in health and disease, but the current 
understanding of how smooth muscle cell stiffuess and contractility contribute to vascular 
stiffuess remains incomplete. The research presented in this dissertation investigates the 
involvement of the focal adhesion of the vascular smooth muscle cell in blood vessel 
stiffuess. My specific aims were to (1) examine focal adhesion remodeling with agonist 
and stretch; (2) relate stiffness to contractility; and (3) modify vascular stiffness with 
focal adhesion protein decoys. There is a growing body of evidence, mostly from airway 
tissues, that the smooth muscle focal adhesions are not static structures as previously 
thought, but rather they bear some resemblance to their counterparts in the well-studied 
migrating cell model system (Somlyo 1980; Gunst and Zhang 2008; Zhang and Gunst 
2008). I hypothesized that focal adhesions are dynamic in differentiated vascular smooth 
muscle cells, and in this thesis I have demonstrated that agonist stimulation triggers focal 
adhesion signaling, growth, and remodeling in artery (Chapter 3) and vein (Chapter 4). 
Next, I hypothesized that focal adhesion growth and remodeling are important to the 
mechanical properties of smooth muscle. I have demonstrated that the focal adhesion 
functions as a regulator of both tissue stiffuess and contractile force transmission to the 
37 
tissue in both artery (Chapter 3) and vein (Chapter 4). Interestingly, I found that both 
focal adhesion signaling and focal adhesion regulation of stiffness are impaired with age 
(Chapter 5). Finally, I hypothesized that synthetic, cell-permeable peptide decoys could 
be introduced in diseased vascular smooth muscle cells to modify focal adhesion protein-
protein interactions and artificially reduce stiffness. I tested several candidates using a 
high-throughput assay of cell adhesion, a surrogate for stiffness and focal adhesion 
function, and I found at least one peptide that deserves further study (Chapter 6). 
Collectively, these results indicate that the focal adhesion of vascular smooth 
muscle is essential for proper biomechanical function in health and aging. This work 
contributes to our understanding of the focal adhesion in vascular smooth muscle, which 
may prove a source of targets for future therapeutic interventions for treating vascular 
stiffening and cardiovascular disease. 
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Chapter 2: Materials and Methods 
2.1 Ethical Approval 
All procedures were performed in accordance with protocols approved by the 
Boston University Institutional Animal Care and Use Committee (Permit Number: 
A3316-0 1 ). The animals (C57bl6/J mouse or ferret) were maintained according to 
guidelines in the NIH Guide for the Care and Use of Laboratory Animals and were 
obtained and used in compliance with federal, state, and local laws. Tissue removal was 
quickly performed after isoflurane euthanasia. 
2.2 Cell Culture 
A 7r5 vascular smooth muscle cells, originally derived from rat aorta (American 
Type Culture Collection, Manassas, VA), were cultured in Dulbecco's modified Eagle ' s 
medium (DMEM, high glucose, Invitrogen, Carlsbad, CA) supplemented with 10% fetal 
calf serum (FCS, Invitrogen), 1% glutamine (Invitrogen), 50 units/ml penicillin 
(Invitrogen), and 50 Jlg/ml streptomycin (Invitrogen) (Vetterkind, Saphirstein et al. 
2011 ). A 7r5 cells proliferate as myoblasts and, when they reach the stationary phase, 
upon serum deprivation, differentiate into a phenotype that resembles adult smooth 
muscle cells (Kimes and Brandt 1976; Firulli, Han et al. 1998). The cells express many 
key markers of smooth muscle, including smooth muscle a-actin, smooth muscle myosin, 
smooth muscle tropomyosin isoforms, hl calponin, and SM22 a (Gimona, Kaverina et al. 
2003). This approach was chosen over primary cultured cells because of the variability of 
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differentiation state with passages (Chamley-Campbell, Campbell et al. 1979). For all 
experiments, A 7r5 cells were seeded onto coverslips or, for magnetic tweezers 
experiments, 35-mm glass-bottom culture dishes (MatTek, Ashland, MA), grown to 75-
90% confluence in the presence of serum and then completely serum-starved for 24 hours 
to trigger differentiation to the quiescent (non-proliferating, non-migrating) smooth 
muscle phenotype. 
2.3 Bead Coating and Attachment 
For magnetic tweezer studies, an arginine-glycine-aspartic acid (RGD) peptide 
(GRGDNP, Enzo Life Sciences, Farmingdale, NY) was covalently coupled to amine-
modified superparamagnetic Dynabeads M-270 (3% solids or 30 mg/ml stock 
concentration, 2.8 Jlm, Invitrogen) according to a protocol from Bangs Laboratories 
(TechNote 205: Covalent Coupling, Bangs Laboratories, Inc., Fishers, IN). The amine-
modified Dynabeads were suspended in 100 J.LL phosphate buffered saline (PBS) at a 
concentration of 10 mg/ml (or 1% solids), and washed twice. A wash consists of pelleting 
the beads for 4 min with the Dynal magnet (Invitrogen), discarding the supernatant, and 
resuspending the beads at 10 mg/ml in PBS. Then the beads were activated by suspension 
in 10% glutaraldehyde (an amine-reactive homobifunctional cross-linker) in PBS for 1-2 
h at room temperature with continuous mixing and vortexing at regular intervals. After 
two washes, the beads were resuspended in PBS and reacted with RGD peptide (0.5 
mg/ml) for 2-4 h at room temperature with continuous mixing. Next, the beads were 
washed once and resuspended in quenching solution consisting of 40 mM glycine with 
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1% (w/v) bovine serum albumin (BSA, Invitrogen) as a blocking agent for 30 min at 
room temperature with continuous mixing. Finally, the beads were washed once and 
stored at 4°C for up to two months in PBS with 0.1% (w/v) BSA and 0.05% sodium 
azide. 
For optical tweezer studies, the same protocol was employed to covalently couple 
the RGD peptide to Rhodamine B-conjugated, amine-modified, melamine fluorescent 
microspheres (2.5% solids or 25 mg/ml stock concentration, 2 !lm, Corpuscular, Cold 
Spring, NY). As these beads are not magnetic, they were pelleted by brief centrifugation 
(several seconds) in a standard benchtop rnicrocentrifuge. 
RGD is an ECM protein motif that is a minimal sequence required for binding by 
transmembrane integrin receptors (Martinez-Lemus, Wu et al. 2003). The GRGDNP 
peptide has affinity for the a5~ 1 and av~3 integrins, which are present in vascular smooth 
muscle tissues and recognize fibronectin and vitronectin, respectively (Pierschbacher and 
Ruoslahti 1987; Mogford, Davis et al. 1997; Martinez-Lemus, Wu et al. 2003). 
Before making stiffness measurements, the beads were washed and sonicated. 
Then 6.7 x 105 beads were added to the 35-mm glass bottom dish containing cells for 
magnetic tweezers measurements or to the wells in 6-well plates containing coverslips for 
optical tweezers measurements. The beads were incubated with the cells for 30 min at 
37°C with 5% C02 to facilitate their attachment to the cells. Following this incubation, 
the serum-free medium was exchanged twice to remove unbound beads. Measurements 
of cortical stiffness were performed at room temperature. Measuring time was limited to 
30 minutes per dish. 
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2.4 Measurement of Cellular Stiffness 
2.4.1 Optical Tweezers 
Optical tweezer (OT) experiments were conducted at Dr. Jeffrey Moore's 
laboratory (Boston University Medical Campus) on a hybrid optical trapping, bright field, 
and epifluorescence microscope based on the Nikon TE2000 model, allowing 
simultaneous visualization of cells and measurement of the mechanics of cell-bead 
attachment. Briefly, the beam from a variable power, 4W Yttrium-Aluminum-Garnet-
laser (4 W, SpectraPhysics, Mountain View, CA) was expanded with a 5X telescope and 
directed to fill the back aperture of a 1.3 NA lOOx objective on a Nikon Eclipse TE2000-
U inverted microscope (Nikon Instruments, Melville, NY) through a system of lenses and 
mirrors. Laser beam position was controllable by a set of acousto-optical deflectors 
(NEOS Technologies, Gooch & Housego, Melbourne, Florida). For calibrating trap 
stiffness, the position of trapped beads was monitored using a quadrant detector (MBPS, 
Spectral Applied Research, Richmond Hill, ON, Canada) illuminated with a brightfield 
Xenon source. Signals from the quadrant detector were recorded using Lab VIEW 8.6 and 
a PCI-6220 card (National Instruments, Austin, TX). The quadrant detector response was 
calibrated by moving a bead across the linear region of the detector, and the trap stiffuess 
was determined by monitoring the Brownian motion of a trapped bead in water using the 
equipartition theorem, similarly to what has previously been done (Neuman and Nagy 
2008). The mean trap stiffness was 0.1 pN/nm. After calibrations, the trap was positioned 
over the center of the quadrant detector using the acousto-optical deflectors and kept 
there for subsequent cell experiments. 
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Technical challenges with freshly dissociated smooth muscle cells necessitate the 
use of serum-starved A 7r5s, a model of differentiated VSMCs, for stiffuess 
measurements with OT. Incubation of RGD peptide-coated microspheres for 30 minutes 
with the A 7r5 cells allows their binding to cell-surface integrins and attachment to the 
underlying focal adhesion and cortical actin cytoskeleton. The beads function as handles 
for pulling with OT. Lysophosphatidic acid (LPA, 10 J..LM) was added for 15 minutes, or 
PP2 (1 0 J..LM) was added for 30 minutes followed by LP A for 15 minutes. Coverslips 
were mounted on a microscope piezostage, a two-axis nanopositioner (Mad City Labs, 
Madison, WD, at room temperature. Solutions were changed every ten minutes to ensure 
adequate hydration and oxygenation of the cells. Measurement time with the OT for each 
sample was limited to 30 minutes to ensure cell viability. 
To measure cortical stiffuess, which we defme as the stiffuess of the bead-integrin 
attachment and the underlying FA and cortical cytoskeleton, a cell-adherent bead is 
positioned at the center of the OT. The trap is turned on and its position held constant 
while the piezostage is stepped (1 0 steps, 100 nm/step, 3 s/step ), displacing the cell and 
cell-bound bead relative to the trap. Shortly after each step, the competing forces exerted 
on the bead by the trap and the displaced cell balance, and the bead no longer moves 
(force equilibrium). The position of the bead was recorded using an Andor iXon+ camera 
(Andor Technology, Belfast, Northern Ireland) and the Nikon NIS Elements imaging 
software (Nikon Instruments). This information was later processed with the 
ParticleTracker plug-in in ImageJ (Sbalzarini and Koumoutsakos 2005) and analyzed in 
Matlab (Natick, MA). The force F exerted by the trap on the bead is the product of the 
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trap stiffness ktrap and the distance of the bead from the center of the trap Axbead· The 
displacement of the bead from its starting position relative to the cell Axcelb along with 
the force exerted by the cell on the bead (equivalent to the force from the trap at 
equilibrium), were visualized as force-extension curves. Regression fitting was 
performed to obtain the slope of the force-extension plots, herein called cortical stiffness, 
which encompasses the stiffness of the bead-integrin attachment and the underlying FA 
and cortical cytoskeleton. 
2.4.2 Magnetic Tweezers 
The magnetic tweezers (MT) apparatus is modeled after a system designed by the 
Fabry group (Kollmannsberger and Fabry 2007), and it consists of a magnetic 
microneedle made from a cylindrical rod of high-permeability, low-hysteresivity nickel 
alloy (HyMU-80, Carpenter Technology, Reading, PA) with a 4.5-mm core diameter and 
its needle-end sharpened to a 40-!lm radius (courtesy of the Boston University machine 
shop); a solenoid (200 turns of 0.5 mm copper wire) surrounding the microneedle; and a 
power supply (MPJA, Lake Park, FL) connected to the solenoid. 
Calibration of the magnetic tweezers was performed similarly to what has been 
done by others (Kollmannsberger and Fabry 2007). Briefly, the movements of beads 
through a viscous mixture of 3:1 glycerol to ddH20 (viscosity 1J = 0.052 Pa s at room 
temperature) were used to compute forces on the beads for different solenoid currents 
using Stokes' formula for viscous drag, F = 6rt1J11l, where 1J is the viscosity, r is the radius 
of the bead, and v is the velocity of the bead through the mixture. The calibration data for 
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all beads were then fit to a simple empirical equation relating the force on a bead to both 
the bead's distance from the magnetic tweezers tip and the current through the solenoid 
using Matlab (Kollmannsberger and Fabry 2007). This relationship was then used to 
analyze data· from cortical stiffness experiments and calculate forces exerted on cell-
bound beads based on their distance from the MT tip and the set current. 
To measure cortical stiffness, the MT tip is positioned approximately 150-200 J..Lm 
from a cell-adherent bead using a micromanipulator. This distance was chosen because 
the force-distance relationship is highly nonlinear at short bead-tip distances but flattens 
out at distances greater than 100 J..Lm. Thus, at an operating distance of 150-200 J..Lm, a 
pull on a bead will displace it towards the tip and only negligibly increase the force 
exerted by the MT on the bead (i.e., force is essentially constant, F ~ 50 pN). An 
operating current of 1.5 A was chosen for experiments because it produces low forces 
appropriate for cortical probing (Rotsch, Jacobson et al. 1999; Matthews, Overby et al. 
2004; Kasas, Wang et al. 2005; Oberleithner, Callies et al. 2009). At this low current (and 
for the short pull durations employed), there is no significant heating of the rod or the 
sample. Between measurements, the stage is displaced a distance of at least 0.5 mm so 
that cells do not experience forces from previous measurements. Beads selected for 
analysis are less than 50 J..Lm from the cell edge and bound on the MT -side of the cell, 
sufficiently far from the nucleus, to avoid pulling the bead uphill. Additionally, beads 
were selected for pulling only if there were no overlapping cells in the vicinity of the 
bead that could influence the local apical topography of the cell. 
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Cortical stiffness, which we defme as the stiffness of the bead-integrin attachment 
and the underlying FA and cortical cytoskeleton, was measured by employing a priming 
protocol described by others that consists of a series of five identical square-wave cycles 
that are 4 sec in duration and 4 sec apart (Matthews, Overby et al. 2004; Matthews, 
Overby et al. 2006). Each pull displaces the bead towards the MT probe, and in between 
pulls the bead recoils and reaches equilibrium. The bead does not return to its exact start 
position with each pull, leading to a shift in the baseline with each pulse that stabilizes 
within about three pulls. The fifth and final pull is analyzed to measure cortical stiffness 
(calculated as a ratio of the force applied to the displacement of the cell-adherent bead). 
Experiments were performed at 20x magnification (NA 0.5) with a Nikon Plan 
Fluor objective under bright-field illumination on an Eclipse TE2000-E inverted 
microscope (Nikon Instruments). Videos of beads and the MT tip were recorded in real 
time with a charge-coupled device camera (CoolSNAP HQ2, Photometries) at 10 frames 
per second using the Nikon NIS Elements imaging software (Nikon Instruments). 
Positions of beads were tracked with an intensity-weighted center-of-mass algorithm 
using the MTrackJ plug-in for ImageJ (Meijering, Dzyubachyk et al. 2012) and later 
analyzed in Matlab. 
For experiments in A7r5s, lysophosphatidic acid (LPA, 10 J..!M) was added for 15 
minutes, PP2 (10 J..!M) was added for 30 minutes, or PP2 was added for 30 minutes 
followed by LP A for 15 minutes. Experiments were performed at room temperature, and 
measurement time with the MT for each sample was limited to 30 minutes to ensure cell 
viability. For experiments in freshly-isolated portal vein smooth muscle cells, 
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measurements were made for 10 minutes on unstimulated cells at room temperature, and 
then the cells were stimulated for 10 minutes by replacement of the solution with 
oxygenated, pre-warmed solution (37°C) containing 10 f.!M phenylephrine (a stable 
chemical analogue of norepinephrine) before repeat measurements were made in the 
same set of cells over the next 1 0 minutes. 
2.4.3 Atomic Force Microscopy 
The Nanoscope V atomic force microscope (Veeco, Lowell, MA) in Dr. Ophelia 
Tsui's lab (Boston University) with silicon nitride cantilevers having a pyramidal tip 
(NP-SlOD, Veeco) with dimensions of 10-40 nm and spring constant of 0.06 N/m was 
used in contact scanning mode (frequency 1 Hz) to acquire topographical images of 
randomly selected A 7r5 VSMCs (n=5 cells, 1 experiment). After image scanning, the 
AFM probe was directed to a specified location on the cell between the nucleus and the 
cell edge. A standard procedure in the V eeco AFM software was executed to maneuver 
the probe in tapping mode to poke the cell and obtain a force-distance curve. The raw 
curve was processed with custom written Matlab code (Dongdong Peng, Dr. Tsui Lab, 
Boston University) to obtain force-indentation curves. Force is calculated by Hooke's 
Law, F = kfu, where k is the probe spring constant and fu the measured deflection. The 
initial deflection of the cantilever occurs when it contacts the cell, and it is determined by 
evaluating the point of departure from linearity to non-linearity in the approach curve. 
The force indentation relationship can then be fitted with the Hertz model to obtain the 
elastic modulus E (Sun and Meininger 2011). 
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2.5 Immunofluorescence Imaging and Analysis 
A7r5 cells and portal vein dVSMCs (without 300 mM sucrose) were fixed in 4% 
paraformaldehyde, quenched with 0.1 mM glycine, permeabilized with 0.1% Triton X-
100, blocked with 10% goat or donkey serum, and stained as previously described 
(Parker, Takahashi et al. 1998; Vetterkind, Saphirstein et al. 2011). Nuclei were stained 
with 4,6-diamidino-2-phenylindole (Sigma-Aldrich, St. Louis, MO), and filamentous 
actin was stained with Alexa Fluor 568 and 488 phalloidin (1 :3000, Invitrogen). Cells 
were examined with an Eclipse TE2000-E fluorescence microscope (Nikon Instruments) 
equipped with a Nikon Plan Apochromat 60X (NA 1.4) oil immersion objective, a 
charge-coupled device camera (CoolSNAP HQ2, Photometries), and filters optimized for 
double-label experiments. NIS-Element Advanced Research software (Nikon 
Instruments) was used to capture images and for removal of out-of-focus fluorescent blur 
by deconvolution of Z-stacks (Richardson-Lucy algorithm, constrained iterative-
maximum likelihood estimation algorithm) as previously described (Min, Reznichenko et 
al. 2012). Subsequent processing was completed with Photoshop CS3 software (Adobe 
Systems, Mountain View, CA). 
Areas of individual F As were determined usmg NIS-Elements Advanced 
Research software. FAs were measured for 5 to 13 A7r5 cells per condition (control, PP2, 
LPA, PP2 + LPA) per experiment (total n=82 cells). In each cell that was selected for 
analysis, all peripheral F As were examined for analysis because these adhesions are most 
relevant to the question of force transmission, as numerous studies have reported that the 
largest traction forces are found in the cell periphery (Cai and Sheetz 2009). Cells with 
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overlapping neighbors that would obscure measurements were excluded from the 
analysis. 
2.6 Tissue Preparation 
C57bV6 Mice (Mus musculus) (3 months old or 29 months old) (Charles River, 
Wilmington, MA) or ferrets (Mustela putorius Jura) (Marshall Farms, North Rose, NY) 
were euthanized with an overdose of isoflurane by inhalation. The aorta (from mice) or 
the hepatic portal vein (from ferrets) was promptly excised, rinsed six times to remove 
blood within or around the vessel, which can harm the smooth muscle cells and induce 
vasoconstriction (Bulter, Peterson et al. 1996), and stored in an oxygenated (95% 0 2 -
5% C02) physiological salt solution (Krebs PSS) (in mM: 120 NaCl, 5.9 KCl, 1.2 
NaH2P04, 25 NaHC03, 11.5 dextrose, 1CaCh, and 1.4 MgCh; pH= 7.4). The tissue was 
carefully dissected in oxygenated PSS to remove connective tissue and adventitia. For 
mouse aorta, aortic rings were cut ( 4 mm long) then suspended in vitro in tissue baths 
containing oxygenated PSS at 37°C for force and stiffness measurements. Smaller rings 
immediately proximal and distal to these suspended segments were also cut for 
determining ring thickness. For ferret portal vein, the vessel was opened longitudinally, 
since SMCs in portal vein are axially oriented, in contrast with circumferentially oriented 
aortic SMCs (Bohr, Somlyo et al. 1980). The endothelium was removed by gently 
rubbing the lumen with a rubber policeman. Rectangular strips (1 mm wide x 5 mm long) 
were suspended in tissue baths containing oxygenated PSS at 37°C for force and stiffness 
measurements, or small square pieces (16 pieces, 2 mm x 2 mm, length by width) were 
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cut for subsequent enzymatic digestion for cell isolation. Following the measurements 
made in the tissue baths, aortic rings or portal vein strips were quick-frozen at -78.5°C in 
a slurry of dry ice and liquid acetone containing 10 mM dithiothreitol and 10% TCA for 
subsequent biochemical analysis (Marganski, Gangopadhyay et al. 2005). The TCA 
functions to denature and deactivate endogenous kinases, phosphatases, and proteolytic 
enzymes, thereby preserving the levels of phosphorylation present at the time of freezing 
(Driska, Aksoy et al. 1981; 1996). Freezing of the thin-walled mouse aorta rings 
occurs rapidly in comparison to the minute timescale for phosphorylation events, 
contraction, or relaxation. 
2. 7 Enzymatic Dissociation of Cells from Ferret Portal Vein Tissue 
Single vascular smooth muscle cells from ferret portal vein were isolated using a 
modification of a previously published protocol (DeFeo and Morgan 1985). Ferret portal 
vein tissue (wet weight ~ 60 mg) was dissected and cleaned as described above then cut 
into 16 small pieces (2 mm x 2 mm). These pieces were placed in a siliconized flask 
containing digestion solution. For siliconization, flasks were previously filled with 
Sigmacote (Sigma-Aldrich) for 20 min, air-dried overnight, baked for 1 hour at 110°C, 
soaked overnight in ddHzO, and then rinsed several times before use. Digestion solution 
A contained 9.5 mg of CLS 2 collagenase (type II, 220 units/mg, Worthington 
Biochemical, Lakewood, NJ) and 5 mg of elastase (grade II, 5.41 units/mg, Roche, 
Indianapolis, IN) in 7.5 ml ofCa2+-Mg2+- free HBSS (Hanks Buffered Salt Solution) with 
0.27 mg/ml trypsin inhibitor (type II soybean T-9128, Sigma) and 0.075% BSA. Ca2+ is 
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not present in the solution because an influx of extracellular calcium into VSMCs can 
trigger contraction and shortening, and Mg2+ is not included because it is necessary for 
cross-bridge cycling. The tissue pieces were incubated in a shaking water bath at 35°C in 
the presence of 100% 0 2 for 40 minutes. The contents of the flask were then poured 
(since aspiration induces shortening) over a nylon mesh (Spectra/Mesh polypropylene 
filter, 500 J.Lm pore size, 39% open area, thickness 610 J.Lm; Spectrum Laboratories, 
Rancho Dominguez, CA) and into a second siliconized flask. The tissue pieces caught on 
the filter were then rinsed with 10 mL Ca2+, Mg2+- free HBSS, and the rinsing was also 
caught in the second flask. The contents of the second flask were poured onto 2 N NaOH-
etched coverslips or 2 N NaOH-etched MatTek plates. These coverslips or plates were set 
aside and kept on ice in an oxygen-rich environment. The tissue pieces were then 
reincubated for 20 min in digestion solution B (similar to digestion solution A but with 
the collagenase content reduced by half). As before, the filtrate and rinses containing the 
dissociated cells were poured over a new set of etched glass coverslips or etched MatTek 
GBPs. The remaining pieces caught on the filter were incubated for 20 min in the first 
flask in digestion medium C (the same as digestion medium B). After filtering, rinsing, 
and plating as in the previous two steps, a fourth digestion was performed for 20 min 
with digestion medium D (containing no elastase or collagenase), and the resultant filtrate 
and rinses were poured over another set of coverslips or plates. All cells were allowed to 
plate on ice in an environment with 100% 0 2 for one hour, during which Ca2+ and Mg2+ 
were added back gradually in logarithmic fashion (up to final concentrations of 1 mM 
and 1.173 mM, respectively) to avoid inducing cell shortening. Isolated cells were tested 
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at room temperature to confirm shortening in response to 51 mM KCl or 10 JlM PE. After 
re-addition of Ca2+ and Mg2+, the batches with the most cells and best shortening 
response to contractile stimulus (generally batches 3-4) were used for experiments. Cells 
were stored 1-5 hr on ice until use. 
2.8 Measurement of Tissue Thickness 
Aorta ring thickness was measured to determine cross-sectional area for stiffness 
calculations. Thin tissue rings were cut from both ends of an aorta ring segment prior to 
measuring its stiffness in the tissue bath. The thin rings were incubated with 2 drops/ml 
of NucBlue (Life Technologies, Grand Island, NY), a vital nuclear stain, for 30 minutes. 
Each ring was placed in a small PSS-filled chamber on a slide with the major axis of the 
vessel perpendicular to the slide for examination in cross-section. Images were taken 
under the blue channel (cell nuclei) and the green channel (autofluorescent internal elastic 
laminae) at 20x, moving around the ring to acquire a total of six images for thickness 
measurements (Figure 3A, inset). For each of the six images, four line segments were 
arbitrarily drawn to measure stiffness at different positions on the vessel wall. All twenty-
four measurements per ring were averaged. Then, the thicknesses of the two bordering 
thin rings were averaged to determine the mean thickness of the aorta ring segment ( - 60 
Jlm). The cross-sectional area of the portal vein strips was estimated by dividing the 
measured wet mass of the vascular strip by the product of its slack length and the density 
of water (which is close to the density ofbiological tissues). 
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2.9 Tissue Stiffness Measurements with Sinusoidal Perturbations 
2.9.1 Aorta Rings 
For in vitro force and stiffness measurements, thin triangular shaped wire clasps 
(d = 0.005 in) were threaded through the lumen of the aorta rings then attached at one end 
to a fixed hook and at the other end to a computer-controlled motorized lever arm (Dual-
Mode Lever Arm System, Model 300C, Aurora Scientific, Ontario, Canada) capable of 
setting tissue length while simultaneously measuring force. The rings were stretched 
uniaxially in the circumferential direction, as vascular smooth muscle cells in the aorta 
wall are oriented primarily in this direction, and this is the primary direction of strain 
induced by pulsatile flow in vivo. 
Rings were stretched to optimal length L0 (1.8 x slack length, or equivalently a 
strain E = 80%) for 30 minutes to allow adequate time for stress relaxation (i.e., for 
tensile force to stabilize at a steady state level). The optimal length for maximal 
contraction was predetermined by length-tension curves (data not shown); for mouse 
aorta, L 0 is near the upper end of the tissue's physiologic strain range during 
systolic/diastolic pressure transients (Wagenseil and Mecham 2009). Following this step, 
the tissue was stimulated to contract for 15 minutes by depolarization with physiologic 
saline solution in which 51 mM NaCl had been replaced by KCl, followed by a series of 
three washouts with regular PSS and a 30 minute relaxation period. The observation of 
the magnitude of the KCl contractions confirms viability and adequate equilibration of 
the tissue. Then rings were incubated with vehicle (DMSO, 1: 1,000; or ethanol 1: 1,000), 
PP2 (10 f.!M), FAK inhibitor-14 (Fl-14) (10 f.!M), or ML-9 (10 f.!M) for an additional 30 
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minutes. Stiffuess measurements at optimal length Lo were collected continuously during 
ten minutes of stimulation with the alpha-agonist phenylephrine (PE, 10 J..LM) at a 
maximally effective concentration. 
2.9.2 Portal Vein Strips 
Portal vein tissue strips were secured on opposite ends to a force transducer 
(Force Displacement Transducer Model FT03, Grass Technologies, West Warwick, RI) 
and a motorized lever arm (High-Speed Length Controller Model 322C-I, Aurora 
Scientific, Ontario, Canada). Briefly, two small, T -shaped pieces of aluminum foil were 
each secured to a different end of the tissue strip by wrapping the arms of the T around 
the tissue and then crimping them. Small holes were punched through the base of each of 
the T -clips, and the tissue strip was then mounted for stiffuess measurements by 
threading through those holes small hooks fixed to the lever arm and the force transducer 
as previously described (Brozovich and Morgan 1989; Rhee and Brozovich 2000). Strips 
were stretched to optimal length L 0 (1.7 x slack length) for 30 minutes. Strips were 
incubated with vehicle (DMSO, 1:1 ,000; or ethanol1:1 ,000), PP2 (10 J..LM), or ML-9 (10 
J..LM) for an additional 30 minutes. Stiffuess measurements at optimal length Lo were 
collected continuously during ten minutes of stimulation with the alpha agonist 
phenylephrine (PE, 10 J..LM), a maximally effective concentration. 
2.9.3 Sinusoidal Perturbations 
Tissue stiffuess was measured by small-amplitude, high-frequency sinusoidal 
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length perturbations as previously described (Brozovich and Morgan 1989; Rhee and 
Brozovich 2000). For aorta rings, 1% oscillations at 40 Hz were employed; for portal 
vein strips, 1-2% oscillations at 50 Hz were employed. This regime has previously been 
shown to measure total tissue stiffness without breaking actin-myosin crossbridges 
(Brozovich and Morgan 1989). With oscillatory stretching, tissue stiffness E = E' + iE', 
where E' is the elastic or storage modulus (the in-phase component of the stiffness), E" is 
the viscous or loss modulus (the out-of-phase component of the stiffness), and i is the unit 
imaginary number. As reported previously (Brozovich and Morgan 1989), with this 
protocol the force and length signals are in-phase, and therefore the out-of-phase viscous 
component of the stiffness is negligible. Thus, the tissue's elastic modulus, or material 
stiffness, E is calculated as the ratio of the stress a- to the strain s, E = (!1FIA)/(M!L0 ), 
where I1F is the amplitude of the force response to the cyclic stretches, A is the cross-
sectional area, M is the amplitude of the cyclic stretches, and L0 is the optimal length. 
When stretched to optimal length, the walls of the aorta ring collapse, allowing the cross-
sectional area A to be calculated as twice the product of the wall thickness h and the axial 
length of the ring /, A = 2hl. For portal vein strips, the cross-sectional area A of the strip 
is approximated as A = m/(p*Lstack) , where m is the measured mass of the vascular strip, 
L siack is the slack length, and p is the density of water, which is close to the density of 
biological tissues. 
2.10 Aorta Tissue Stiffness Measurements with Quasi-Static Stress-Strain Curves 
Aorta tissue stiffness was measured by quasi-static stretching of rings from 0 to 
55 
100% strain at a constant loading/unloading rate of 0.1 Hz. A train of five of such 
stretches was performed. Since these loading curves stabilize after the first two stretches, 
the loading curves for the final three stretches were averaged and converted into stress-
strain curves. Stiffness at the optimal length was taken as the slope of the stress-strain 
curve at 80% strain. Analysis was performed using Matlab with custom code (written by 
Yuan Gao, Dr. Morgan lab, Boston University). 
2.11 Western Blot Analysis and Measurement ofLC20 Phosphorylation 
Quick-frozen tissues were homogenized and processed for Western blotting of 
10% SDS-polyacrylamide gels at 4 oc as previously described (Marganski, 
Gangopadhyay et al. 2005). The homogenization buffer was designed to preserve 
phosphoproteins, and it consists of20 mM MOPS, 4% SDS, 10% glycerol, 10 mM DTT, 
20 mM i)-glycerophosphate, 5.5 !-lM leupeptin, 5.5 !-lM pepstatin, 20 KIU aprotinin, 2 
mM Na3V04, 1 mM NaF, 100 !-lM ZnCh, 20 !-lM AEBSF, and 5 mM EGTA. Western 
blot densitometry was performed using Odyssey Infrared Imaging System (LI-COR 
Biosciences, Lincoln, NE). Glycerol-urea gel electrophoresis was performed to separate 
nonphosphorylated, monophosphorylated, and disphosphorylated light chains as 
previously described (Min, Reznichenko et al. 2012), and LC20 phosphorylation was 
calculated as a ratio of phosphorylated LC20 to total LC20. LC20 phosphorylation was 
examined 30 seconds into stimulation with PE, before both stiffness and contractile force 
reach their maximal values, as we have shown previously that this time point corresponds 
to maximum LC20 phosphorylation in aortic smooth muscle (Jiang and Morgan 1989). 
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2.12 Synthesis of TAT Decoy Peptides 
Decoy peptides were generously provided by Dr. Paul Leavis of the Boston 
Biomedical Research Institute (Watertown, MA). The cell-permeable peptides (CPPs) 
were synthesized with an Applied Biosystems model 433A peptide synthesizer by solid-
state peptide synthesis using fluorenylmethoxycarbonyl chemistry (Kim, Gallant et al. 
2008). The pro-peptides, acetylated at their N termini to block the N-terminus of the 
peptide for subsequent FITC attachment, 
GRPLLQAAKGLAGA VSELLRSAQPA), 
NSRKLLSAAKILADATAKMVEAAKG), and 
were TLN-VBSl 
TLN-VBS2 
TLN-VBS3 
(Ac-
(Ac-
(Ac-
YTKKELIECARRVSEKVSHVLAALQ), and corresponding scrambled peptides TLN-
VBSlX (Ac- LLRRSQAALGAAAEVLPQALSGPGK), TLN-VBS2X (Ac-
KKMDSIVRAGKLATNALALEAASKA), TLN-VBS-3XA (Ac-
IA VYELHSKSARKKTRELCVLVEAQ), and TLN-VBS-3XB (Ac-
EVYIEELLASKVRTQLKCAHKSV AR). These sequences correspond with three 
vinculin binding sites on mouse talin that are conserved in the human version of the 
protein (Gingras, Ziegler et al. 2005). All pro-peptides were then synthetically coupled to 
a TAT protein transduction domain comprising residues YGRKKRRQRRR (which 
mediates transfer of the peptide across the cell membrane and into the cell (Abes, 
Arzumanov et al. 2007)) and a FITC label (for confirming loading of the peptide into 
cells or tissue) to form the active versions of the peptides. 
A fluorescent label was added to the peptide by constructing an orthogonal bridge 
consisting of epsilon-aminohexanoic acid-FITC on the side chain of the first lysine 
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residue (K4) of the TAT sequence. The alpha-amino group of this residue was protected 
during the initial synthesis by the acid labile 4-methyltrityl group, which was 
subsequently removed from the peptide by five consecutive 1-min treatments with 2% 
trifluoroacetic acid plus 3% tri-isopropylsilane, leaving the peptide still attached to the 
resin with all other reactive side chains still protected. The peptides were cleaved and 
purified to >95% using reversed-phase high-performance liquid chromatography. 
2.13 High-throughput Cell Adhesion Assay for Testing Cell-Permeable Peptides 
A high-throughput cell attachment assay was developed as a preliminary screen to 
assess the efficacy of cell-permeable peptide (CPP) constructs in altering focal adhesion 
function in A 7r5 VSMCs. Cell adhesion here serves as a potential surrogate for stiffness. 
Confluent A7r5s were trypsinized (0.05% trypsin, Sigma) andre-plated for one hour in 
the presence of 10 J..LM CPP, 10 J..LM scrambled peptide, or vehicle control. After one hour, 
the medium containing the unattached cells was aspirated and stored on ice, and the cells 
were counted with a hemocytometer. The adherent cells were gently scraped off the plate 
with a rubber tool instead of by trypsinization because the early adhesions formed by 
these cells were observed to be trypsin insensitive for up to 1 hr in 0.16% trypsin. The 
scraped-off adherent cells were stored on ice and counted. The ratio of unattached cells to 
attached cells was used for comparison of the different conditions. A peptide that yields a 
significant increase or decrease in this ratio versus the controls may alter focal adhesion 
function to potentially decrease or increase stiffness, respectively. After counting, the 
cells were spun down, and then the pellet was resuspended in phosphate lysis buffer 
58 
(50 mM NaCl, 3 mM MgCh, 1 mM dithiothreitol and 0.5% Nonidet-P40 in a 10 mM 
sodium phosphate buffer, pH 8.0) supplemented with protease inhibitor cocktail (Roche) 
for Lowry protein assay, which confirmed the results obtained with the hemocytometer. 
2.14 Fabricating Tunable-Stiffness Polyacrylamide Gels on Coverslips 
Polyacrylamide (P AAM) gel substrates were synthesized on coverslips and 
functionalized with fibronectin following a protocol courtesy of Corin Williams of Dr. 
Joyce Wong's lab at Boston University (Pelham and Wang 1997; Leach, Brown et al. 
2007; Sazonova, Lee et al. 2011). The first step in this protocol is glass coverslip 
activation, which is necessary for attachment of the gel. 25-mm round cover slips (No. 1, 
Fisher Scientific, Pittsburgh, P A) were marked opposite to the side to be activated with a 
fine point marker. Coverslips were run quickly over a Bunsen burner flame then placed 
with the flame-activated side face-up. Then 0.1 N NaOH was smeared on the flame-
activated side of the coverslips with a cotton swab. The coverslips were allowed to air dry 
for 10 min and then were smeared with 3-aminopropyltrimethyoxy silane (Sigma-
Aldrich). After air-drying for 10 min, the coverslips were washed with distilled water 
then placed in 6-well plates filled with distilled water for 10 min on a shaker. Next the 
distilled water was aspirated from the wells, and the coverslips were covered with 0.5% 
glutaraldehyde in PBS for 30 min. The glutaraldehyde was washed with distilled water, 
and then the coverslips were stored in fresh distilled water at 4 ac until their use. When 
ready for use, the activated coverslips were air-dried. Meanwhile, an equal number of 
new, non-activated round glass coverslips were laid flat on top of microcentrifuge tubes 
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spaced far enough apart in a microcentrifuge tube rack so that the cover slips do not touch 
each other. A 10 f.!l drop of distilled water was used between the bottom surface of the 
coverslips and the tube lids to hold the coverslip on top of each tube. Then, the first five 
polyacrylamide gel ingredients listed in Table 2.1 were mixed and degassed by vacuum 
for 15 min, after which TEMED was added to the gel mixture (TEMED addition initiates 
polymerization at a slow rate). Since the gel at this point is basic (pH ~ 10-11 ), which 
inhibits both NHS ester and polymerization, drops of 1M HCl were added until the pH 
was 6-6.8. Next, the NHS, which crosslinks the fibronectin (Millipore, Billerica, MA) in 
the gel, was added, followed by the APS to trigger rapid polymerization. 40 f.!l of solution 
was quickly pipetted on top of the non-activated cover slips on the rack, and each was 
carefully covered with an activated cover slip. This sandwich yields gels with a thickness 
~80 f.!m. After pipetting, the remaining gel mixture was used to cast a gel for tensile 
measurement of Young's modulus. Once the gels polymerized (30-40 min at room 
temperature), the non-activated coverslip was removed with a razor and discarded. The 
gels on coverslips were placed in 6 well plates, washed with PBS, and stored at 4°C for 
no more than 1-2 days before use. The mechanical properties of the gels can change over 
time and with temperature, so must be determined on the same day as the experiments are 
performed. 
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Component Standard recipe for Alternative recipe 
traction*** (from Olga Sazonova)*** 
Acrylamide (AAM) 1 ml 1.25 ml 
Bis 150 Jll 250 Jll 
lOX PBS 500 Jll 500 Jll 
Distilled water 3.13-3.155ml 2.78-2.805 ml 
Fibronectin 10-20 Jll 10-20 Jll 
TEMED 10 Jll 10 Jll 
*HCl 50-75 Jll 50-75 Jll 
**Fluorescent beads 50 Jll 50 Jll 
NHS 50 Jll 50 Jll 
APS 25 Jll 25 Jll 
Table 2.1. Recipe for 5 ml of polyacrylamide gel solution for gels on coverslips. 
* A rough estimate that may vary with HCl stock. Adjustment of the distilled water 
volume may be necessary to stay within 5 ml total volume. 
** For traction gels only. If gels are not for traction force microscopy, replace with 
equal volume of distilled water. 
*** The standard gel has a final AAM/bis concentration of 8%/0.06% with an 
expected tensile modulus of 5-10 kPa. Sazonova's recipe yields a gel with a final 
AAM!bis concentration of 10%/0.1% and an expected tensile modulus around 25 kPa. 
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After three rinses with PBS or Hanks solution, A 7r5 cells or freshly-isolated 
portal vein dVSMCs were seeded onto the gels and adhered via the fibronectin presented 
on the gel surface (fibronectin was added to the bulk of the gel mixture in this protocol 
for convenience). Modifications of the gel mixture were made to tune gel stiffness to 
optimize adhesion of these cells (Isenberg, Dimilla et al. 2009). In future studies, the 
addition of fluorescent microbeads to the gel mixture would enable traction force 
microscopy studies (Pelham and Wang 1997). 
2.15 Reagents and Antibodies 
Agonists used were LPA from Cayman Chemical (Ann Arbor, MI) and 
phenylephrine from Sigma-Aldrich. PP2 was purchased from EMD Biosciences (La 
Jolla, CA); FAK inhibitor 14 was purchased from Santa Cruz Biotechnology (Santa Cruz, 
CA); and ML-9 was purchased from Calbiochem (La Jolla, CA). General laboratory 
reagents were of analytical grade or better and purchased from Sigma-Aldrich and Bio-
Rad Laboratories (Hercules, CA). The following primary antibodies were used: phospho-
tyrosine (mouse, 1:500) and phospho-FAK Y397 (mouse, 1:500) from BD Biosciences 
(San Jose, CA); phospho-FAK Y925 (rabbit, 1:200), phospho-paxillin Y118 (rabbit, 
1 :250), and phospho-CAS Y165 (rabbit, 1 :250) from Cell Signaling Technology 
(Danvers, MA); vinculin (mouse V4505, 1:400) from Sigma-Aldrich; zyxin (goat, 1:500) 
from Santa Cruz Biotechnology; ~ 1 integrin (mouse, 1:100) from Millipore; and a-tubulin 
(rabbit, 1:50,000 from Abeam (Cambridge, MA). For immunofluorescence experiments, 
goat or donkey anti-rabbit and goat or donkey anti-mouse Alexa Fluor 488 and Alexa 
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Fluor 568 (1: 1,000; Invitrogen) were used as secondary antibodies. For Western blot 
experiments, Goat Oregon Green 488 or Alexa Fluor 568 labeled anti-rabbit or anti-
mouse IgGs were used as secondary antibodies (1:1 ,000; LI-COR Biosciences, Lincoln, 
NE). 
2.16 Statistical Analysis 
Data are reported as means +/- standard error. Differences between individual 
means were determined by two-tailed Student's t-test unless otherwise stated. Differences 
were considered significant at p<0.05. 
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Chapter 3: Vascular Smooth Muscle Regulation of Aortic Stiffness 
3.1 Summary 
Aging-associated increased aortic stiffness is an acknowledged predictor and 
cause of cardiovascular disease. The sources and mechanisms of vascular stiffness are not 
well understood, although the extracellular matrix (ECM) has been assumed to be a major 
component of aging-induced increases. We tested here the hypothesis that the focal 
adhesions (F As) connecting the cortical cytoskeleton of vascular smooth muscle cells 
(VSMCs) to the matrix in the aortic wall are a component of aortic stiffness and that this 
component is dynamically regulated. First, we examined cellular cortical stiffness with 
magnetic tweezers in serum-starved A 7r5 aortic smooth muscle cells. Lysophosphatidic 
acid (LPA), an activator of myosin that increases cell contractility, increased cortical 
stiffness. A small molecule inhibitor of Src-dependent FA recycling, PP2, was found to 
significantly inhibit LPA-induced increases in cortical stiffness, as well as tension-
induced increases in FA size. To directly test the applicability of these results to force and 
stiffness development at the level of vascular tissue, we monitored mouse aorta ring 
stiffness with small sinusoidal length oscillations during agonist-induced contraction. The 
alpha-agonist phenylephrine, which also increases myosin activation and contractility, 
increased tissue stress and stiffness in a PP2- and FAK inhibitor 14-attenuated manner. 
Subsequent phosphotyrosine screening and follow-up with phosphosite-specific 
antibodies confirmed that the effects of PP2 and F AK inhibitor 14 in vascular tissue 
involve FA proteins, including F AK, CAS, and paxillin. Thus, we identify, for the first 
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time, the FA of the VSMC, in particular the FAK-Src signaling complex, as a significant 
subcellular regulator of aortic stiffness and stress. 
3.2 Introduction 
Normal cardiovascular function depends on the biomechanical properties of blood 
vessels, and changes in these properties are characteristic of disease. Increased aortic 
stiffness precedes and predicts for the development of hypertension and subsequent 
negative cardiovascular outcomes, including myocardial infarction, stroke, and heart 
disease (Mitchell, Hwang et al. 2010; Kaess, Rong et al. 2012). A stiffer aorta deforms 
less in response to pulse pressure, absorbing less of the pulse while transmitting a greater 
portion of the potentially harmful pulsatile energy downstream to delicate vessels of the 
microcirculation in the heart, lung, brain and kidneys (Mitchell, Hwang et al. 201 0). 
The mechanical properties of a blood vessel, like any material or tissue, are 
determined by its components and their organization. Accordingly, the stiffness of 
vascular tissue can be derived from the composition of the extracellular matrix (ECM) 
and the cells in the tissue, the organization of the matrix and cells, and the connections 
that link these components (cell-matrix and cell-cell contacts). The prevailing view is that 
the ECM is the principal determinant of vascular stiffness (Greenwald 2007); however, 
the extent to which other tissue components contribute is unclear. 
Vascular smooth muscle cells (VSMCs ), the predominant cell type in the wall of 
large blood vessels, influence tissue stiffness when modulating contractile tone or when 
depositing matrix or matrix-degrading enzymes (Brozovich and Morgan 1989; 
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Greenwald 2007). Recently, the stiffness of VSMCs themselves has been implicated as 
an important determinant of tissue stiffness (Qiu, Zhu et al. 2010), with the actin 
cytoskeleton suggested as the specific cellular component responsible. Based on this 
finding, as well as the recent fmding that the cortical actin cytoskeleton is dynamic in 
vascular smooth muscle tissue (Kim, Gallant et al. 2008), we hypothesized that the 
cortical focal adhesions (F As) (also known as adhesion plaques or dense plaques in 
smooth muscle tissues (Small 1985)) may be an important, and possibly regulated, 
component of vascular tissue stiffness. Here we defme the FA to include its attachments 
to the cortical actin cytoskeleton as well as the integrins that attach the cell to the ECM. 
In the present study, we examine the mechanical properties of blood vessels 
across multiple length scales and identify, for the first time, the Src-FAK signaling 
complex ofF As of the non-migratory, non-proliferating VSMCs embedded in the blood 
vessel wall as a significant regulator of aortic stiffness. Finally, we show that FA size, 
cortical stiffness, and VSMC contractility influence the FA-regulated component of 
aortic stiffness. 
3.3 Results 
3.3.1 Aortic VSMC cortical stiffness is modulated by FAs and contractile 
activation 
To test the role ofF As in regulating cell stiffness, minimizing the contribution of 
the ECM, we measured cortical stiffness of serum-starved A 7r5 VSMCs with MT (Figure 
3.1A). For these experiments, the position of the magnetic probe tip was adjusted to be in 
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Figure 3.1. Cortical stiffness measurement in VSMCs with magnetic tweezers 
(Saphirstein, Gao et al. 2013). (A) Controlled force pulses generated by magnetic tweezers 
displace aortic VSMC-adherent, RGD-coated superparamagnetic beads (2.8 f..Lm) to measure the 
stiffness of the bead-focal adhesion-cortical cytoskeleton linkage (see Methods) . The force F 
exerted on a bead depends on the induced magnetic moment in the bead m and the spatial 
gradient of the magnetic field B, which depends critically on the sharpness of the probe 's tip, 
characterized by its radius of curvature R. (B) Calibration curve relating the force exerted on a 
bead (d = 2.8 f..Lm) to its distance from the MT tip (R = 40 f..Lm) and the current through the 
electromagnet solenoid (I = 1.5 A). The gray box denotes the operating range used for the MT 
experiments, i.e., the distance that is set between the MT tip and a bead before pulling 
commences. (C) Mean cortical stiffness increases with LPA stimulation in a PP2-attenuated 
manner. Right: BSA beads, which do not bind integrins but adhere nonspecifically, do not 
register an increase in stiffness with LPA. *p<0.05, **p<O.Ol, n.s. -not significant, unpaired, 
two-tailed Student's t-test, assuming unequal variances. 
67 
the more linear range of the force-distance calibration curve (Figure 3.1B). The low 
forces used here (~50 pN) confine stiffness measurements to the cortex of the cell 
(Rotsch, Jacobson et al. 1999; Matthews, Overby et al. 2004; Kasas, Wang et al. 2005; 
Oberleithner, Callies et al. 2009), encompassing the bead-integrin attachment as well as 
the underlying FA and cortical cytoskeleton. 
Mean cortical stiffness (Figure 3.1C) was measured with RGD-coated beads in 
order to bind integrins (0.122±0.015 pN/nm). A7r5 cells do not respond to classical 
vasoconstrictors, but stimulation with non-mitogenic LP A mimics vasoconstrictors such 
as PE since it increases myosin phosphorylation to activate myosin (Jones, Ella et al. 
1994; Chrzanowska-Wodnicka and Burridge 1996; Min, Reznichenko et al. 2012). LPA 
increased stiffness (0.159±0.018 pN/nm) significantly (p<0.01), but pre-treatment before 
LP A stimulation with PP2, a specific small molecule inhibitor that prevents FA 
remodeling by inhibiting Src family kinases (Fincham and Frame 1998; Webb, Donais et 
al. 2004; Bain, Plater et al. 2007; Min, Reznichenko et al. 2012), reduced cortical 
stiffness to untreated baseline levels. These results directly implicate the FA and the 
surrounding cortical cytoskeleton in agonist-induced increases in stiffness of the bead-
ECM-cytoskeleton linkage in A 7r5 VSMCs. 
As a control, we performed experiments with bovine serum albumin (BSA)-
coated beads, which adhere nonspecifically to cell membranes (Sun, Martinez-Lemus et 
al. 2008). There was no difference between cortical stiffness measured with RGD beads 
and BSA beads in the absence of a stimulus; however, measurements of stiffness with the 
BSA beads did not exhibit the increase in stiffness observed with RGD beads following 
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LPA stimulation of the A7r5 VSMCs (Figure 3.1C), thereby confirming the existence of 
a functional focal adhesion linkage between the RGD beads and the underlying cortical 
cytoskeleton. 
Experiments performed with optical tweezers (OT) also demonstrated a PP2-
attenuated increase in cortical stiffness from LP A stimulation, verifying our results from 
the magnetic tweezers experiments (Figure 3.2). The OT experiments were actually 
performed first chronologically, and the simpler magnetic tweezers apparatus was 
developed afterwards in our laboratory to facilitate the transition to measuring cortical 
stiffness in freshly-isolated differentiated vascular smooth muscle cells. The values of the 
stiffness measured with either method differ, although the numbers are within the same 
order of magnitude, and this likely arises from differences in the pulling protocols 
employed (repeated pull-release for MT vs. staircase for OT) or the beads (e.g., their 
slightly different diameters, or the different densities of surface amine groups between 
beads from different manufacturers, and therefore, differences in the amount of RGD 
peptide coating the bead surface). Additionally, we performed a single-experiment pilot 
study with atomic force microscopy (Figure 3.3). This method has the ability to probe 
cortical stiffness anywhere on the cell surface, not just at the site of cell-bound beads, so 
could be useful for future studies. It is worth pointing out that stiffness obtained with the 
AFM (in the tens of pN/nm range) was larger than that obtained either by OT or MT. 
This is probably due to differences in the direction and nature of the forces employed. 
AFM applies compression via indentation normal to the cell surface, whereas OT and MT 
apply tension tangential to the cell surface. In AFM the contact geometry of the 
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Figure 3.2. Cortical stiffness measurement in VSMCs with optical tweezers (A) 
Application of force with optical tweezers to measure cortical stiffness. Aortic VSMC-
adherent, RGD-coated bead is centered in the stationary trap, and the cell is displaced 
relative to the trap with the piezostage. The force on the bead is measured at steady state 
after each step. (B) Top: Bead displacement trace. Bottom: Force-extension plot. Cortical 
stiffness is the slope of this plot. (C) Mean cortical stiffness, calculated from force-
extension plots. **p<O.Ol , one-way ANOVA and post hoc Tukey-Kramer test. 
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Figure 3.3. Cortical stiffness measurement in VSMCs with atomic force microscopy. 
(A) Topographical image of two aortic VSMCs imaged by atomic force microscopy 
(contact mode). The oval marks an area in the right-hand cell between the nucleus 
(yellow) and the cell edge that was used for stiffness measurements. Scale bar: 20 J...Lm. 
(B) Force-indentation plots obtained by AFM (indentation mode) for several cells, 
indicated by different colors (n=l experiment, 5 cells). 
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pyramidal tip indenting the cell surface is well defined, and this contact geometry is quite 
different from that between the spherical microbead and the cell surface in OT and MT 
studies. 
3.3.2 LP A stimulation increases FA size in a PP2-attenuated manner 
We hypothesized that changes in FA dimensions might underlie our cortical 
stiffness observations since F As of migrating cells grow in a force-dependent manner 
(Bershadsky, Balaban et al. 2003), and Src, together with F AK, is known to affect FA 
recycling and growth in nonmuscle cells (Webb, Donais et al. 2004). Thus, we 
quantitated FA sizes using deconvolution immunofluorescent imaging of vinculin, a 
marker ofF As (Figure 3.4). 
Mean FA size did not change with PP2 treatment alone. F As were significantly 
larger in cells stimulated with LPA (4.97±0.26 Jlm2 versus 3.24±0.14 Jlm2 in control 
cells, a 55% increase) (p<0.001). This is consistent with effects reported in migrating 
cells upon myosin activation and suggests that a tension-induced increase in FA size in 
the presence of LPA increases cortical stiffness. Additionally, the growth in FA size with 
LP A was prevented by PP2, which is also consistent with the known effect of PP2 to 
prevent FA remodeling and growth in other cell types (Fincham and Frame 1998; Webb, 
Donais et al. 2004). Vinculin has multiple actin binding sites and is known to crosslink 
actin and the FA (Mierke 2009); hence, increased vinculin staining may reflect additional 
actin-FA interactions and concurrent stiffening and strengthening of the FA and the 
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Figure 3.4. LPA stimulation increases FA size in a PP2-sensitive manner 
(Saphirstein, Gao et al. 2013). Top: Deconvolution microscopy of FAs. Representative 
F As are shown in an expanded view in the insets. All F As in each cell, not just those 
featured in the insets, were analyzed to determine the mean FA area. Scale bars: top, 20 
J.lm; bottom, 5 J.lm. Bottom: Mean FA area is significantly greater in cells stimulated with 
LPA (n=82 cells). ***p<O.OOl , unpaired, two-tailed Student's t-test. 
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surrounding cortical cytoskeleton. There was no statistically significant difference 
between the number of focal adhesions per unit area (0.054±0.003 J.lm-2) in any of the 
conditions examined. 
3.3.3 Contractile filament activation is a component of agonist-induced aortic 
tissue stiffness 
To extend our vascular smooth muscle cell studies to vascular tissue, we 
measured stiffness of mouse aorta rings in vitro with small-amplitude sinusoidal stretches 
that do not break crossbridges (Brozovich and Morgan 1989). This stretching produces an 
in-phase force response that simplifies the stiffness calculation to a normalized ratio of 
the force response to the imposed length cycling (see Methods). The sample force trace 
(Figure 3.5A) illustrates the continuous measurement of both force generation (the rise of 
the trace) and stiffening (the widening of the force response with constant amplitude 
length perturbations) during stimulation with the vasoconstrictor PE. Additionally, the 
sample trace demonstrates the importance of smooth muscle cell activation as a 
modulator of aortic wall stiffness, as it represents roughly 20% of total stiffness. The 
remaining 80% of the stiffness of activated tissue equals the baseline, unstimulated 
stiffness (213 +/- 7 kPa), which is likely determined largely by the ECM. Changes in 
stiffness ("stiffening") are plotted in Figure 3.5 as opposed to absolute stiffness, as the 
focus of this study is to examine the contribution of the smooth muscle cell component 
rather than the matrix component to stiffness. 
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Figure 3.5. Aortic tissue stiffening during contractile stimulation is decreased by 
inhibition of Src, FAK, or MLCK (Saphirstein, Gao et al. 2013). (A) Tissue stiffness E 
measured in vitro during PE-induced contraction at optimum length L0 with small-amplitude 
(1 %), high frequency (40Hz) sinusoidal stretches M. Box height and width for magnified traces: 
0.5 mN, 5 j.lill, and 0.02 s. Upper Inset: Stiffness calculation. Lower Inset: Fluorescent 
micrograph of aortic ring in cross-section, used to determine ring thickness for calculation of 
cross-sectional area A. Green: autofluorescent elastic laminae. Blue: cell nuclei. Scale bar, 100 
j.lill. (B) PE-induced stress is significantly lower when pre-treated with MLCK inhibitor ML-9, 
confirming the importance of myosin activation and contraction to vascular stiffness (n=4). PE-
induced stress is also significantly reduced when pre-treated with Src inhibitor PP2 and F AK 
inhibitor 14. (C) PE-induced stiffening is significantly reduced when pre-treated with MLCK 
inhibitor ML-9, confirming the importance of myosin activation to aortic stiffness. Stiffening is 
also significantly lower when pre-treated with Src inhibitor PP2 and FAK inhibitor 14, indicating 
a role for Src, FAK, and FA proteins in aortic stiffness. n = 10 untreated, 6 ML-9, 4 PP2, 5 FI-14 
rings. *p<O.OS ,**p<O.Ol , ***p<O.OOl , unpaired, two-tailed Student 's t-test. 
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Smooth muscle contractility is regulated by myosin light chain kinase (MLCK)-
dependent myosin phosphorylation (Horowitz, Menice et al. 1996). Rings pre-treated 
with the MLCK inhibitor ML-9 before PE stimulation exhibited a significant decrease in 
stress generation (43-53%) (p<0.05) (Figure 3.5B) and a significant decrease in stiffening 
(47-57%) (p<O.Ol-0.05) (Figure 3.5C). These results demonstrate that the actomyosin 
contractile apparatus of the VSMC is a major component of regulated blood vessel 
stiffness. 
3.3.4 Aortic tissue stiffening is decreased by inhibition of Src or F AK 
To test the role ofF A remodeling in regulating stiffness of the intact vessel wall, 
we measured the stiffness of aortic rings pre-treated with PP2 before PE activation. PP2 
significantly decreased PE-induced stiffening (71-84%) (p<O.OO 1-0.05) (Figure 3 .5C). 
These results are consistent with the concept that Src-dependent FA recycling is a 
significant regulator of aortic stiffness. 
Unexpectedly, PP2 pre-treatment also significantly decreased PE-induced stress 
generation (78-88%) (p<O.OOl-0.05) (Figure 3.5B). At first glance, the magnitude of this 
decrease suggests that PP2 might directly alter smooth muscle contractility, possibly by 
an effect on Rho (via p190RhoGAP). RheA/Rho-kinase signals downstream to MLC 
phosphatase, increasing MLC phosphorylation (Somlyo and Somlyo 2003; Huveneers 
and Darren 2009). We have previously published that the alpha-agonist PE increases 
myosin phosphorylation and activation (Shin, Je et al. 2002) and that the concentration of 
PP2 employed here does not affect MLC phosphorylation in aortic tissue of the ferret 
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(Min, Reznichenko et al. 2012). We have now confirmed by urea gel analysis that PE 
induces MLC phosphorylation in mouse aorta, unaffected by PP2 (unstimulated, 
untreated: 0.218 +/- 0.046 mol P04/mol LC; PE: 0.375 +/- 0.049 mol POJ mol LC, 
p<0.05; PP2+PE: 0.362 +/- 0.039 mol P04/mol LC, n.s., n = 5). Src is also known in 
some systems to regulate actin polymerization (Huveneers and Danen 2009). In vascular 
smooth muscle tissue, actin remodeling induced by PE has been shown to be largely 
cortical (Kim, Gallant et al. 2008). Thus, the inhibition of Src function by PP2 seems to 
involve solely the focal adhesion and the associated cortical cytoskeleton, presumably 
hindering the transmission of force from the contractile filaments across the focal 
adhesion. 
We also measured stress and stiffness for aortic rings pre-treated with the specific 
small molecule inhibitor FAK inhibitor 14 before PE activation (Golubovskaya, Nyberg 
et al. 2008). As with PP2, FI-14 also significantly decreased PE-induced stiffening (40-
73%) (p<0.01-0.05) (Figure 3.5C) and stress generation (47-96%) (p<0.01-0.05) (Figure 
3.5B). Taken together, these results implicate the FAK-Src signaling complex ofthe focal 
adhesion as a regulator of tension and stiffness in the aortic wall. 
3.3.5 Src- and FAK- mediated tyrosine phosphorylation of FA proteins parallels 
increases in aortic stiffness 
To confirm that PP2 inhibits Src-dependent FA signaling in aortic tissue, we 
performed phosphotyrosine screens of aorta homogenates. As seen in Figure 3.6A and B, 
PE increases tyrosine phosphorylation, and PE-induced increases in phosphotyrosine are 
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Figure 3.6. PE stimulation induces FAK- and Src-mediated tyrosine 
phosphorylation of FA proteins in aortic dVSMCs (Saphirstein, Gao et al. 2013). (A) 
Typical blot, phosphotyrosine screening of mouse aorta tissue homogenates. PE increases 
tyrosine phosphorylation, and pre-treatment with Src inhibitor PP2 decreases tyrosine 
phosphorylation. (B) Mean densitometry of phosphotyrosine bands indicated. (C) 
Phospho-FAK Y925 increases in response to PE in a PP2-inhibitable manner, mean 
densitometry (n=9 mice, 3 experiments). (D-E) Phospho-CAS Y165 and phospho-
paxillin Y118 increase in response to PE in a FI-14-inhibitable manner, mean 
densitometry (n=9 mice, 3 experiments). The brightness of the representative bands in 
Insets C-E has been uniformly altered for visual display; however, unaltered images were 
used for densitometry quantitation. *p<0.05, **p<O.Ol vs. control, +p<0.05, ++p<O.Ol, 
+++p<O.OOl vs. PP2+PE or FI-14+PE, unpaired, two-tailed Student's t-test. 
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inhibited by PP2, notably for bands at 130, 125, 120 and 68 kDa (p<0.001-0.05). These 
bands have been previously shown to correspond to focal adhesion proteins, including 
CAS, FAK, and paxillin, in aorta tissue from the ferret (Min, Reznichenko et al. 2012). 
The p125 band co-stained with an antibody against 125-kDa FAK, a major FA 
signaling protein and Src binding protein (Mitra, Hanson et al. 2005). A F AK Y925-site-
specific phospho-antibody confirmed the presence of a significant PE-induced increase in 
phosphorylation and a significant inhibition of the PE effect by PP2 (p<O.O 1) (Figure 
3.6C). FAK Y925 is a Src substrate that signals downstream to ERK (Mitra, Hanson et al. 
2005), which is also known to be activated by PE in aortic tissue (Khalil, Menice et al. 
1995; Dessy, Kim et al. 1998; Min, Reznichenko et al. 2012). 
To further explore agonist-induced FA signaling, we examined phosphotyrosine 
levels in the presence of FAK inhibitor 14. Phospho-specific antibodies against p130 
CAS Y165 and p68 paxillin Y118, both substrates of the FAK-Src signaling complex 
(Mitra, Hanson et al. 2005), demonstrated statistically significant PE-induced increases in 
phosphorylation that are significantly inhibited by FI-14 (p<0.01-0.05) (Figure 3.6D and 
E). 
Thus, taken together, these results are consistent with the concept that, at the 
tissue level, vasoconstrictor activation initiates Src- and F AK -dependent FA signaling, 
which, in turn, regulates aortic stiffness and contractility. 
3.4 Discussion 
The main finding of this chapter is that the FA, as a cell-matrix linker, via the 
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FAK-Src signaling network, is a significant and regulated component of aortic stiffness 
and tone. As a first step towards determining whether the cytoskeleton-FA linkage 
modulates vascular tissue stiffness, we measured cortical stiffness on the surface of aortic 
smooth muscle cells. To the best of our knowledge, our use of MT to measure cortical 
stiffness in VSMCs is novel but complementary to other techniques employing larger 
forces to sample whole cell stiffness (Deng, Trepat et al. 2006; Sun, Martinez-Lemus et 
al. 2008). Others have shown that the nanometer lengths and piconewton forces we used 
with the MT are sufficiently small and weak to restrict perturbations to several hundred 
nanometers into only the cortex of the cell (Rotsch, Jacobson et al. 1999; Matthews, 
Overby et al. 2004; Kasas, Wang et al. 2005; Oberleithner, Callies et al. 2009). The 2.8-
f..Lm beads used for these experiments, roughly the size of individual F As in these cells, 
allow selective probing of individual F As. Both our bead and tissue deflections reflect 
strains that are less than 1%, insufficient to disrupt crossbridges (Brozovich and Morgan 
1989). Although the MT force range can evoke local responses from individual FA 
proteins in vitro (Choquet, Felsenfeld et al. 1997; Felsenfeld, Schwartzberg et al. 1999; 
Geiger, Bershadsky et al. 2001; Wang, Botvinick et al. 2005), these forces are insufficient 
to activate large-scale biological responses, such as micromyogenic responses in VSMCs 
(Sun, Martinez-Lemus et al. 2008), which could obscure cortical measurements. Pulling 
with the MT is in the lateral direction, in contrast to the perpendicular indentation or 
retraction of atomic force microscopy or the torsion of magnetic twisting cytometry. 
Lateral pulls are closer to the direction of insertion of actin stress fibers into the cortex 
(North, Gimona et al. 1994) and, therefore, sample cortical stiffness in a physiologically 
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relevant direction. 
The MT experiments revealed that cortical stiffness is increased by contractile 
stimulation with LP A in a Src-dependent manner. Cell immunofluorescence imaging was 
employed to explain the effects of LP A and PP2 on cortical stiffness. The imaging data 
demonstrate that contractile activation with LP A induces FA growth, similar to what has 
been observed in migrating and spreading cells (Chrzanowska-Wodnicka and Burridge 
1996), likely due to increased intracellular load on FAs (Bershadsky, Balaban et al. 
2003). The A 7r5s cells are strongly adherent to the coverslips and do not shorten when 
stimulated, although they do activate contractile signaling pathways as shown by myosin 
light chain phosphorylation (V etterkind, Lee et al. 201 0). Therefore, the increase in FA 
area is not due to a decrease in cell size, which might bring distant F As into close 
proximity or merge them into a single unit. Additionally, our measurements in the tissue 
were made at constant length, which rules out such effects at that length scale. Other 
investigators have reported that the relationship between FA size (based on vinculin 
staining) and traction forces in non-migrating cells is linear, i.e., larger F As correlate with 
larger traction forces (Balaban, Schwarz et al. 2001; Bershadsky, Balaban et al. 2003). A 
more recent study finds that this relationship holds only during the initial stages of 
myosin-mediated nascent adhesion maturation and growth and that FA size and traction 
forces are not correlated for mature adhesions (Stricker, Aratyn-Schaus et al. 2011). This 
suggests that the focal adhesions in our system, when stimulated by vasoconstrictors, may 
more closely resemble dynamic nascent adhesions than mature focal adhesions. Since in 
our system of non-migrating smooth muscle cells we examined FA size using vinculin as 
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a marker, larger FAs may also reflect increased vinculin cross-linking of actin to the FA 
(Mierke 2009). Thus, one may speculate that larger F As, and the additional actin 
associated with them, form a stiffer, stronger link between the inside and outside of the 
cell, which is necessary to stably transmit greater forces to a cell's substrate 
(Chrzanowska-Wodnicka and Burridge 1996). Additionally, we have previously shown 
by differential centrifugation in aorta of the ferret that CAS and Src redistribute in 
response to agonist stimulation; therefore, similar remodeling of the FA likely 
accompanies FA growth in response to agonist in rodent aorta (Min, Reznichenko et al. 
2012). 
After demonstrating that FAs and especially the FAK-Src signaling network are 
important to the cortical stiffening of a VSM cell model during contractile stimulation, 
we scaled up to in vitro stiffness measurements of rodent aorta. We found that smooth 
muscle contraction accounts for roughly 20% of stiffness, with the remaining 80% likely 
being due to extracellular matrix. Others have published that the ECM plays an important 
role in determining tissue stiffness and that changes in the ECM that occur with age or 
disease can affect tissue stiffness (Greenwald 2007), but the workings of the smooth 
muscle component of stiffness are not as well understood. We found that FI -14 inhibited 
~60% of vascular stiffening and ~50-95% of stress generation during stimulation, and 
PP2 inhibited ~ 70% of vascular stiffening and ~80% of stress generation during 
stimulation without affecting myosin light chain phosphorylation, which, together with 
our examination of phosphotyrosine signaling in the F AK-Src pathway in this tissue, is 
consistent with the concept that the FA, including cortical cytoskeletal connections, is a 
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major regulator of stiffness. This finding is noteworthy given that until recently F As in 
contractile vascular smooth muscle embedded in blood vessel walls were considered to 
be relatively static structures, in contrast to their highly dynamic analogues in migrating 
cell types (Bershadsky, Balaban et al. 2003). Similarly, tyrosine phosphorylation ofF A 
proteins, particularly by F AK and Src, is the hallmark of their turnover in migrating, 
cultured cells (Bershadsky, Balaban et al. 2003; Webb, Donais et al. 2004) but has only 
recently been studied in contractile smooth muscle (Li, Gallant et al. 2007; Zhang and 
Gunst 2008; Min, Reznichenko et al. 2012). Since essentially all other known signaling 
events regulating contractile filament activation in contractile VSMCs involve serine or 
threonine phosphorylations (Horowitz, Menice et al. 1996), tyrosine phosphorylation 
events in these cells appear to be largely linked to the dynamics ofF A proteins and the 
associated cortical actin cytoskeleton. 
Taking these findings together, it appears that agonist-induced FA growth and 
remodeling entails strengthening of cytoskeleton-matrix linkages in VSM, permitting 
adequate force transmission from contracting cells to the vascular wall (see Model, 
Figure 3.7A). Prevention of FA/cortical cytoskeletal recycling via FAK-Src signaling, 
and by preventing FA growth, inhibits both force transmission and stiffuess development 
(Figure 3.7B). Conversely, prevention of myosin activation directly inhibits force 
transmission and, by decreasing cytoskeletal tension, appears to also prevent FA growth, 
which decreases stiffuess and further inhibits force transmission (Figure 3.7C). The fact 
that cortical actin and FA remodeling are concurrent in this system (Kim, Gallant et al. 
2008) might lead to changes in output via a FA-actin cytoskeleton "clutch" mechanism 
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described for other cell types (Hu, Ji et al. 2007) that may control the efficiency of force 
transfer to the blood vessel wall. 
Since this study demonstrates that stiffness at the subcellular level plays an 
important role in determining stiffness at the tissue level, we attempted to directly relate 
the stiffness measured at each of these length scales. In Figure 3.1 C, cortical stiffness is 
reported both as an apparent stiffness or spring constant (pN/nm, left y-axis) and as an 
absolute stiffness or Young's modulus (Pa, right y-axis). Since both the cell-bead contact 
area and the cell height in the vicinity of the bead are unknown, the absolute stiffness is 
calculated by estimating the strain as the bead displacement divided by the bead radius 
and by estimating the stress as the applied force divided by the cross-sectional area of the 
bead (Mijailovich, Kojic et al. 2002; Fabry, Klemm et al. 2011; Mierke 2013). For the 2.8 
!J.m beads used here, measurements of apparent stiffness can be converted to absolute 
stiffness via a multiplicative factor of 0.227 !J.m-1• Thus, we find the resting cortical 
stiffness of the A 7r5 VSMCs is roughly 27.7 Pa. 
Cortical stiffness increases to 36.1 Pa with agonist, a 30% increase that is 
comparable to the 20-25% percent increase in tissue stiffness with agonist stimulation. 
The PP2-inhibitable portion of cortical stiffening is approximately all of the agonist-
induced cortical stiffening, nearly 10 Pa, while the PP2-inhibitable portion of tissue 
stiffening is roughly 70% of the total agonist-induced stiffening, about 30-50 kPa. These 
numbers differ by three orders of magnitude, likely because of the complex organization 
and connectivity of different tissue components. This might also be due to the different 
forces we employed to measure stiffness at the two length scales. The 1% stretches 
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imposed on the tissue generate stresses of about 2 kPa, or 2,000 pN/J..Lm2, which are 
orders of magnitude greater than the 50 pN forces applied to individual focal adhesions 
with the magnetic tweezers. Resolution of this discrepancy would require advanced 
modeling that is beyond the scope of this dissertation. 
In summary, our results point to the FA of the VSMC, specifically through 
interactions of F AK and Src, as a regulator of aortic vessel stiffuess. We report that the 
F As of these nonmigrating cells embedded in the wall of the aorta are regulated by 
vasoconstrictors and coordinate changes in force and stiffuess development in the tissue. 
Given that increases in aortic stiffuess are linked to cardiovascular disease, these results 
also point to the FA as a potential novel therapeutic target. 
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Figure 3.7. Model (Saphirstein, Gao et al. 2013). (A) Tension-induced, Src- and FAK-mediated growth and remodeling of 
dynamic focal adhesions in aortic VSMCs leads to cell-matrix adhesion strengthening (cortical stiffening) in response to 
contractile stimulus. This strengthening is required for adequate force and stiffness transmission from the VSMC to the blood 
vessel wall. (B) Inhibition of Src with PP2 or FAK with FI-14 inhibits FA dynamics and growth, preventing reinforcement of 
the cell-matrix linkage. As a result, forces and stiffness generated by the activated VSMC cannot propagate efficiently to the 
tissue. (C) Inhibition of MLCK with ML-9 reduces contractile force and, as a result, lessens reinforcement of the cell-matrix 
linkage. Consequently, force and stiffness development in the aortic wall are reduced. 
Chapter 4: Regulation of Venous Stiffness by Vascular Smooth Muscle Focal 
Adhesions 
4.1 Summary 
The venous system receives far less attention than the arterial circuit; 
consequently, much less is known about stiffness regulation in the veins. In this chapter, I 
present preliminary work in portal vein testing the hypothesis that venous smooth muscle 
focal adhesions regulate stiffness. The main findings are: (1) that the unstimulated 
material stiffness of the portal vein is much less than that of the aorta; (2) the increase in 
stiffness caused by dVSMC contraction is a much larger proportion of total stiffness in 
portal vein than in aorta; and (3) the focal adhesion regulates venous stiffness. Since the 
veins comprise a reservoir that stores the majority of the blood volume, these findings 
have important implications for venous capacitance and venous return. 
4.2 Introduction 
The venous system functions as a reservoir holding approximately 70% of the 
total blood volume in the circulatory system (Guyton and Hall 2006). The veins 
compnsmg this reservoir are necessarily compliant and, accordingly, possess 
microstructural composition and organization unlike that of arteries (Bohr, Somlyo et al. 
1980). Furthermore, venous smooth muscle cells behave qualitatively differently from 
arteries; for example, dVSMCs in the portal vein exhibit phasic contractions while aortic 
dVSMCs contract tonically (Bohr, Somlyo et al. 1980). 
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Changes in stiffness have been documented in various veins with age and are 
thought to contribute to diastolic dysfunction and orthostatic hypotension, among other 
disorders, by impairing venous capacitance and placing excess load on the heart (Safar 
and London 1987; Gascho, Fanelli et al. 1989; Monahan, Dinenno et al. 2001; Edwards, 
Maurer et al. 2003). Overall, however, the mechanisms of stiffness in veins have received 
little consideration (Brecher 1969; Noordergraaf 1978; Edwards, Maurer et al. 2003; 
Wang, Flewitt et al. 2006). While it is known that the vasoactivity of the veins regulates 
the venous return to the heart (the preload) and thereby determines the volume of blood 
pumped into the arterial system (Rothe 1983; Tyberg 2002), little has been done to study 
the basic mechanisms of vascular smooth muscle regulation of venous stiffness. 
In this chapter, I present ongoing work employing the multi-scale approach of 
Chapter 3 to examine the role of vascular smooth muscle focal adhesions in regulating 
venous tissue stiffness. The experimental model studied in these investigations is the 
ferret hepatic portal vein, which delivers nutrient-rich blood from the capillary beds of 
the digestive tract to the capillary beds of the liver for processing. The liver represents the 
most important source of regional venous return, as it contains roughly 10% of the total 
blood volume and is capable of releasing several hundred milliliters (of a total of about 
five liters) into the circulation in humans (Guyton and Hall 2006). The liver receives 
about 30% of the resting cardiac output, with 75-80% of that entering the liver through 
the high flow, low pressure, and low resistance portal vein and the remainder entering the 
liver through the hepatic artery (Mitzner and Goldberg 1975; Engler, Freeman et al. 
1983; Guyton and Hall 2006; Buob, Johnston et al. 2011). Thus, the experiments that 
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follow could potentially provide insight into both the changes that occur in the venous 
reserve during aging and the mechanisms behind venous diseases. 
4.3 Results 
4.3.1 Focal Adhesions are Smaller in Freshly-Isolated Differentiated VSMCs than 
in Cultured VSMCs 
Focal adhesion size (longitudinal cross-sectional area) in unstimulated, freshly-
isolated portal vein dVSMCs measured by deconvolution fluorescence microscopy was 
compared to that in A 7r5s (Figure 4.1 ). Staining for vinculin, a marker of focal adhesions 
(Geiger, Tokuyasu et al. 1980; Small 1985; Small and Gimona 1998), reveals focal 
adhesions (3.2 +/- 0.1 )lm2) at the termini of actin stress fibers in A 7r5s. In venous 
dVSMCs, vinculin punctae (0.19 +/- 0.2 )lm 2) were observed in close association with 
membrane bound integrin clusters (0.20 +/- 0.02 )lm 2), elongated structures visualized 
using an antibody against B1 integrin, a subunit found in 10 of the 13 kinds of integrins 
present in the vessel wall (Martinez-Lemus, Wu et al. 2003). Immunostaining for zyxin, 
another marker of focal adhesions that is exclusive to mature adhesions in migrating, 
cultured cells (Zaidel-Bar, Ballestrem et al. 2003), exhibited similar size (0.30 +/- 0.20 
)lm 2) and shape as the vinculin punctae, as well as close association with B 1 integrin 
clusters. The roughly tenfold difference in focal adhesion size between these cell types as 
measured by vinculin staining (p<0.001) is likely due to differences in cell phenotype 
arising from difference in environment (e.g., two-dimensional vs. three-dimensional, 
substrate stiffness), and it highlights the importance of studying focal adhesions in 
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dVSMC Vlnculln* fl1 lntegrin* 
Zyxin** 
(not shown) 
Feature Circles Elongated ovals at Circles 
membrane 
Area 0.19 +/- 0.02 ~m2 0.20 +/- 0.02 ~m2 0.30 +/- 0.02 ~m2 
A7r5 VSMC Vlnculln 
Feature Elongated ovals at end of stress fibers 
Area 32 +/- 0.1 1Jm2 
Figure 4.1. Focal adhesion metrics in VSMCs. Immunofluorescent staining for markers 
of focal adhesions. Left Images of freshly-isolated portal vein dVSMCs show vinculin 
punctae (red) closely associated with integrin clusters (green) at the membrane. Scale bar, 
10 JliD. Inset scale bar, 1 urn. (*n=5 experiments, 9 cells; **n=2 experiments, 7 cells). 
Right: Images of A 7r5 VSMCs show vinculin punctae (red) at the termini of actin stress 
fibers (green). Scale bar, 10 JliD. (n=2 experiments, 20 cells) . Focal adhesion area as 
measured by vinculin staining is tenfold greater in the A 7r5s than in the dVSMCs 
(p<0.001). 
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freshly-isolated dVSMCs native to the blood vessel wall. According to the model in 
Chapter 3 (Figure 3.7), focal adhesions are larger when subjected to greater tensions. This 
suggests that the focal adhesions of A 7r5s are under more tension than those in dVSMCs, 
perhaps because the A 7r5s have developed tension by spreading on a stiff, flat glass 
substrate. 
4.3.2 Cortical Stiffening of Venous dVSMCs Induced by Contractile Stimulation 
As FA size is much larger in A7r5s than in freshly-isolated dVSMCs, I 
hypothesized that cortical stiffuess would differ between the two cell types. To test this, I 
made novel measurements in freshly-isolated venous dVSMCs using magnetic tweezers 
with RGD beads (Figure 4.2). I found that cortical stiffuess of dVSMCs (0.134 +/- 0.021 
pN/nm) was significantly increased 10 min during stimulation with PE (0.201 +/- 0.036 
pN/nm) (p<0.05). Contrary to what I hypothesized, both the baseline value of cortical 
stiffness in dVSMCs and the 50% increase in cortical stiffuess due to agonist activation 
are comparable to the measurements made in A 7r5s (Figure 3.1 ). This may be due to 
differences in FA composition between these two cell types. 
4.3.3 Venous Tissue Stiffening is Decreased by Inhibition of Src 
To extend the magnetic tweezers studies of cortical stiffuess in freshly-isolated 
dVSMCs to venous tissue, I measured stiffuess of portal vein tissue strips in vitro with 
small-amplitude sinusoidal stretches that do not break crossbridges (Brozovich and 
Morgan 1989). The sample force trace (Figure 4.3) demonstrates the importance of 
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Figure 4.2. Cortical stiffness increases with PE stimulation. (A) Brightfield image of 
freshly-isolated portal vein dVSMCs with adherent, RGD-coated superparamagnetic 
beads. The tip of the magnetic tweezer is on the right-hand side of the image. Scale bar, 
50 J..Lm. (B) Cortical stiffness was measured before and at 10-20 min during PE 
stimulation in the same cell. Mean cortical stiffness increases significantly with PE 
stimulation. n=21 cells, 5 experiments. *p<0.05, paired, two-tailed Student' s t-test. 
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Figure 4.3. Venous tissue stiffening during contractile stimulation is decreased by 
Src inhibition. (A) Tissue stiffness E measured in vitro during PE-induced contraction at 
optimum length L 0 with small-amplitude (<2%), high frequency (>50Hz) sinusoidal 
stretches !::..L Scale bars for magnified traces: 0.33 mN, 0.15 mm, and 0.1 s. (B) Mean 
stiffness is significantly lower when pre-treated with MLCK inhibitor ML-9, confirming 
the importance of myosin activation and contraction to vascular stiffness (n=4). (C) Mean 
stiffness is significantly lower when pre-treated with Src inhibitor PP2, indicating a role 
for Src and FA proteins in vascular stiffness (n=4). *p<0.05, **p<0.01 , paired, two-tailed 
Student's t-test. 
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smooth muscle cell contraction to venous tissue stiffness. The trace demonstrates a PE-
induced increase in force generation, with the concurrent widening of the trace 
demonstrating an increased tissue stiffness visible as an increased amplitude of the force 
oscillations in response to the constant amplitude sinusoidal length perturbation. The 
sample trace demonstrates the importance of smooth muscle cell activation as a 
modulator of venous wall stiffness, as it represents 45% of the total stiffness of activated 
tissue (in contrast with 20% in the aorta, Figure 3.5). The matrix presumably determines 
the remaining 55% ofthe stiffness (31.8 +/- 3.5 kPa, compared to 213+/-7 kPa in aorta). 
Smooth muscle contractility is regulated by myosin light chain kinase (MLCK)-
dependent myosin phosphorylation. Strips pre-treated with MLCK inhibitor ML-9 before 
PE stimulation exhibited a significant decrease in total active stiffuess of 20-50% 
(p<O.Ol). This is greater than the ~10% decrease in total stiffuess in mouse aorta (when 
considering the 47-57% decrease in PE-induced stiffening in mouse aorta in the context 
of total active stiffuess) (p<0.05) (Figure 4.3B). These results confirm the importance of 
the actomyosin contractile apparatus to venous stiffuess. 
To test the role ofF A remodeling in regulating stiffuess of the intact vein wall, I 
measured stiffuess of portal vein strips pre-treated with PP2 before PE activation. PP2 
significantly decreased PE-induced stiffuess by 17-21% (p<O.Ol-0.05). This is 
comparable to the 20% decrease in total stiffuess in aorta (when considering the 71-84% 
decrease in PE-induced stiffening in mouse aorta in the context of total active stiffuess) 
(Figure 4.3B). It has previously been determined that this concentration of PP2 does not 
affect MLC phosphorylation in ferret vascular tissue, (Min, Reznichenko et al. 20 12); 
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thus, this indicates that Src-dependent FA turnover is also a significant component of 
venous tissue stiffness. 
4.3.4 Src-mediated Tyrosine Phosphorylation ofF A Proteins Parallels Increases in 
Venous Stiffness 
To elaborate the mechanism of VSMC F As in tissue stiffness, and confirm the 
presumed effect of PP2 to inhibit Src-dependent FA signaling in venous vascular tissue, I 
performed phosphotyrosine screens of vascular tissue homogenates (Figure 4.4). 
Phosphotyrosine immunoblots demonstrate that PE increases tyrosine phosphorylation 
and that PE-induced increases in phosphotyrosine are inhibited by PP2, notably for bands 
at 130, 125, 120, and 68 kDa. The p125 band, a representative band from this set that 
additionally exhibits a significant increase in tyrosine phosphorylation with stretch from 
slack to the optimal length (p<0.05) (Figure 4.4B), co-stained with an antibody against 
125-kDa F AK, a major FA signaling protein and Src binding protein (Mitra, Hanson et 
al. 2005). Since F AK is activated by autophosphorylation of Y397 upon integrin 
engagement in migrating cells (Mitra, Hanson et al. 2005), I measured phosphorylation at 
this residue with a site-specific phospho-antibody expecting to see stretch-sensitive 
phosphorylation. No significant changes in FAK Y397 phosphorylation with PE or 
stretch were seen (data not shown), suggesting that perhaps this site is constitutively 
active in smooth muscle cells embedded in the blood vessel wall. In contrast, a F AK 
Y925-site-specific phospho-antibody revealed a significant PE-induced increase in 
phosphorylation (p<0.001) and a significant inhibition of the PE effect by PP2 (p<0.01) 
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Figure 4.4. PE induces Src-mediated tyrosine phosphorylation of FA proteins in 
venous dVSMCs. (A) Typical blot, phosphotyrosine screening of ferret portal vein tissue 
homogenates. PE increases tyrosine phosphorylation and pre-treatment with Src inhibitor 
PP2 decreases tyrosine phosphorylation. (B-C) Mean densitometry: (B) p125 exhibits 
stretch-sensitivity and a PE-induced increase in tyrosine phosphorylation that is inhibited 
by PP2 (n-3). (C) Phospho-FAK Y925 increases in response to PE in a PP2-inhibitable 
manner (n=5). *p<0.05, **p<O.Ol, ***p<O.OOl, paired, two-tailed Student's t-test. 
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(Figure 4.4C). F AK Y925 is a Src substrate that signals downstream to ERK (Mitra, 
Hanson et al. 2005) which is also known to be activated by PE in VSM (Khalil, Menice 
et al. 1995; Dessy, Kim et al. 1998; Min, Reznichenko et al. 2012). FAK Y925 did not 
exhibit stretch sensitivity; so perhaps the stretch sensitivity of p125 is due to another 
protein, such as 120-kDa vinculin. Stretch sensitivity has previously been reported for 
VSMCs, but only a few of the proteins have been identified (Haga, Li et al. 2007). Thus, 
taken together, these results suggest at the tissue level that vasoconstrictor activation 
initiates FAK-Src dependent FA signaling, which, in turn, regulates venous stiffness. As 
FAK-Src signaling and tyrosine phosphorylation have been tied to focal adhesion 
recycling (Fincham and Frame 1998; Webb, Donais et al. 2004), these events might 
function to reinforce the focal adhesion during contraction. 
4.4 Discussion 
This chapter extends the importance of the focal adhesion as a regulator of 
vascular stiffness to the veins, and the results reveal some of the ways in which stiffness 
in veins resembles and differs from stiffness in arteries. The size of focal adhesions 
observed here in A 7r5s is typical for that cell type and comparable to the dimensions of 
focal adhesions in other cultured cells (Chrzanowska-Wodnicka and Burridge 1996; 
Wo1fenson, Henis et al. 2009). The significant difference in size between focal adhesions 
of A 7r5s and freshly-isolated portal vein dVSMCs likely reflects both phenotypic 
differences and the myriad differences between the culture environment and that in vivo 
(e.g., substrate stiffness, geometry, and composition). Although the state of the art 
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remains far from recapitulating the native environment of dVSMCs in vitro, it is well-
established that simply extending the two-dimensional cell culture model into the third 
dimension results in changes in cell behavior, morphology, and focal adhesion profile 
(i.e. , size, distribution, and composition) that are highly variable with culture conditions 
(Cukierman, Pankov et al. 2001). So while it is possible that this may contribute to the 
difference, it is not clear how. Since focal adhesion function could differ in critical ways 
in the cultured cell model, I examined freshly-isolated dVSMCs with the cellular-level 
experiments in this chapter. 
In earlier studies of A 7r5s (Figure 3.4), I demonstrated Src-dependent focal 
adhesion growth with agonist stimulation. Future immunocytochemistry studies with FA 
specific markers are necessary in portal vein dVSMCs to determine whether their F As 
exhibit similar agonist-induced size changes. Inhibitors like PP2, FI-14, and blebbistatin 
could aid in dissecting the underlying mechanisms. Evidence from our lab in vascular 
smooth muscle (Min, Reznichenko et al. 2012; Poythress, Gallant et al. 2013) and others 
in airway smooth muscle (Kim, Hoque et al. 2004; Opazo Saez, Zhang et al. 2004) 
suggest that contractile stimulation of dVSMCs results in focal adhesion protein 
translocation between intracellular compartments ( cytosolic, cytoskeletal, and 
membrane). I suspect that this translocation underlies the changes in focal adhesion size 
and structure that reinforce the mechanical connection between the contractile apparatus 
and the matrix to facilitate force transmission and stiffening. 
Based on differences in focal adhesion sizes between A 7r5s and dVSMCs, I 
expected to measure differences in cortical stiffness. However, the cortical stiffness 
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measured for unstimulated cells of both types were comparable, as was the cortical 
stiffness of stimulated cells of both types. Phosphotyrosine studies revealed FA 
involvement m agonist-induced signaling processes, yet immunofluorescence 
experiments examining the nature of agonist-induced focal adhesions growth in dVMSCs 
are necessary to fully make sense of this observation. The magnetic beads used in the 
magnetic tweezer experiments are 2.8 J.lm in diameter, chosen to correspond to the size of 
individual focal adhesions in A 7r5s to facilitate pulling on single focal adhesion. As focal 
adhesions in dVSMCs are closely packed and much smaller than in A 7r5s, it is possible 
that the 2.8-).lm RGD beads simultaneously pull on multiple focal adhesions. 
Furthermore, whereas A 7r5s are strongly adherent and do not shorten with stimulation, 
dVSMCs can shorten substantially, which may obscure the interpretation of cortical 
stiffness measurements. 
Next, I scaled up to stiffness measurements of portal vein tissue. PP2 inhibited 
~15-20% of vascular stiffness, suggesting that the FA-regulated component is on the 
order of at least ~ 15-20% of total venous stiffness (PP2 inhibited about 20% of total 
stiffness in aorta as well in Chapter 3). Passive matrix stiffness is much lower in portal 
vein than in aorta, as is agonist-induced stress in this tissue. Both are reduced 
significantly in portal vein vs. aorta (p<O.OOl) by about a factor of six. Thus, it would 
appear that VSMCs in either vessel wall are tuned to the stiffness of their surroundings. I 
hypothesize that the qualitative difference in FA size between A 7r5s and portal vein 
dVSMCs will remain during a comparison ofF A size between aortic dVSMCs and portal 
vein dVSMCs and that this difference in size reflects the tuning of the mechanosensitive 
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FA sensor to the distinct mechanical properties of the walls of these vessels. Future 
studies measuring focal adhesion size and cortical stiffness are also necessary to explain 
how A 7r5s with large focal adhesions can have the same unstimulated cortical stiffness 
as portal venous dVSMCs with much smaller focal adhesions. 
There are some key details with regards to the vessels used for these studies. 
Portal vein and aorta were obtained from ferrets and mice, respectively, and the results 
may vary with species. Also the preparation differs in a key respect, namely that portal 
vein strips were denuded, whereas aortic rings had their endothelium intact. Finally, 
uniaxial tests were performed longitudinally for portal vein but circumferentially for 
aorta, as these are the directions in which the dVSMCs in these vessels are mainly 
oriented (Bohr, Somlyo et al. 1980). This may complicate cross-comparison of these 
measurements, especially when one considers that aortic stiffness differs markedly in the 
axial and longitudinal directions (Haskett, Speicher et al. 2012). 
To the best of our knowledge, this is the first time that F As have been implicated 
in the regulation of venous stiffness. The contribution of venous stiffness to vascular 
health is not well understood and is generally underappreciated (Edwards, Maurer et al. 
2003). Although it has been far less studied than arterial stiffening, increases in venous 
stiffness have been demonstrated in venous vessels with age (Mackay, Banks et al. 1978; 
Olsen and Lanne 1998). Veins are many times more compliant than arteries, and the 
majority of blood volume is stored in the venous capacitance bed. Thus, altered venous 
stiffness, perhaps as a consequence of aberrant FA signaling and dynamics, can 
potentially enact large effects on the cardiovascular system. 
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Chapter 5: Vascular Smooth Muscle Regulation of Aortic Stiffness with Age 
5.1 Summary 
The role of the differentiated, contractile vascular smooth muscle cell in abnormal 
aortic stiffening with age is not well understood. Here we tested the hypothesis that the 
focal adhesions of dVSMCs are involved in the development of stiffness in an aging 
mouse model. First, we measured changes in the thickness of the medial layer of the 
aortic wall with age. Then, we examined how the material stiffness of aortic rings differs 
between young and old mice and used a combination of inhibitors and agonists to tease 
out the involvement of the smooth muscle cell. Finally, we examined differences in 
tyrosine phosphorylation, which are linked to focal adhesion signaling pathways. We find 
that agonist-activation of young, healthy aorta initiates a robust increase in tyrosine 
phosphorylation of focal adhesion proteins, whereas this response is largely diminished in 
old aorta. Also, agonist-induced stiffening of old aorta was found to be resistant to 
inhibition by the Src inhibitor PP2. Together, these results suggest that impaired focal 
adhesion signaling may be a component of the changes that occur to the biomechanical 
properties of the vessel wall with age. 
5.2 Introduction 
The components of vascular stiffness are not entirely understood, but they are 
commonly attributed to the major structural proteins of the blood vessel wall, namely 
collagen and elastin (Wagenseil and Mecham 2009). The basic notion is that at low 
pressures, wall tension is born by elastin, but at higher pressures, the collagen fibers in 
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the wall uncrimp and reorient to bear a greater portion of the load and effectively stiffen 
the vessel (Roach and Burton 1957; Holzapfel 2008). The elastin is responsible for the 
elastic recoil of the vessel in response to pulsatile flow, and the collagen protects the 
vessel from damage from over-distension. 
In this context, aortic stiffening with age is viewed as a consequence of 
modifications to the morphology and composition of these proteins (Greenwald 2007; 
Wagenseil and Mecham 2009). One such alteration is the fatigue failure of elastin due to 
repeated loading cycles, which is thought to damage and fragment elastin fibers, 
progressively shifting mechanical loads to collagen fibers and stiffening the vessel. 
Elastin has a relatively long half-life in the body (more than 40 years), but since 
essentially all elastin synthesis is complete by adulthood, there are no mechanisms to 
replace damaged elastin (Shapiro, Endicott et al. 1991 ; Powell, Vine et al. 1992; Davis 
1995). Due to its long half-life, elastin is vulnerable to cumulative damage in the form of 
advanced glycation end-products (AGEs) that can cross-link elastin or collagen 
(Wolffenbuttel, Boulanger et al. 1998; Aronson 2003; Konova, Baydanoff et al. 2004). 
Additionally, elastic arteries are also known to undergo calcification (Dao, Essalihi et al. 
2005; Shao, Cai et al. 2006), as well as enzymatic degradation via matrix metallo-
proteases (MMPs) (Wang and Lakatta 2002; Yasmin, McEniery et al. 2005; Yasmin, 
McEniery et al. 2006), processes that are both promoted by the synthetic VSMCs in the 
vessel wall. 
Studies of the role of vascular smooth muscle cells in aortic stiffening are 
typically concerned with the synthetic subpopulation instead of with the larger 
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differentiated contractile subpopulation. The role of contractile dVSMCs has been 
examined for the most part indirectly in studies of endothelial vasoregulatory dysfunction 
with age (e.g. , reduced production of nitric oxide in vivo) (Gerhard, Roddy et al. 1996; 
Stewart, Millasseau et al. 2003; Wilkinson, Franklin et al. 2004; Soucy, Ryoo et al. 
2006). 
The contractile smooth muscle cell has largely been overlooked because the 
perspective is that it functions as a dynamic tension setter (Wolinsky and Glagov 1964; 
Rachev and Hayashi 1999; Nichols, O'Rourke et al. 2005). It is not thought that the 
VSMC directly contributes to the stiffness of the vessel wall, but rather that it contracts to 
redistribute tensile forces between elastin and collagen and modulate stiffness only on 
short timescales (Wolinsky and Glagov 1964; Rachev and Hayashi 1999; Nichols, 
O'Rourke et al. 2005). Recently, however, this scheme has been challenged by a study 
demonstrating for the first time that the intrinsic stiffness of aortic smooth muscle cells 
increases with age, through mechanisms tied to the actin cytoskeleton, and may 
contribute directly to aortic stiffening (Qiu, Zhu et al. 2010). Since the focal adhesion is 
an important subcellular sensor of the micromechanical niche of VSMCs, we 
hypothesized that the focal adhesion could be at the center of many of the changes in 
aortic VSMC stiffness with age. To test whether focal adhesions regulate aortic stiffening 
with age, we examined their role in an aging mouse model comparing young, 3-month 
old mice (equivalent to 25-year old human) to old, 29-month old mice (equivalent to 75-
year old humans) (Flurkey, Currer et al. 2007). 
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5.3 Results 
5.3.1 Optimal Length for Contraction of Aortic Vascular Smooth Muscle is Age-
independent 
The magnitudes of smooth muscle contractions have long been known to depend 
on strain (Mulvany and Warshaw 1979). The length at which the contractile amplitude is 
maximal is called the optimal length, and experiments examining smooth muscle tissue 
contractility are traditionally conducted at this length. We collected data from aortic rings 
in vitro for active length-tension curves and demonstrated that the optimal length resides 
at 80-120% strain in both young and old mice (Figure 5.1). As 80% strain is the upper 
bound of the physiologic range (W agenseil and Mecham 2009), all tissue samples in this 
chapter were set to this strain for the subsequent experiments. 
5.3.2 Aortic Media Thickens with Age While Aortic Baseline Material Stiffness 
Decreases with Age 
Clinical measures of stiffness are influenced by both vessel geometry and material 
stiffness, which makes it challenging to employ those measures alone to uncover the 
mechanisms of abnormal stiffening with age. Thus, we made separate measurements of 
changes in medial thickness and circumferential material stiffness of aortic rings in vitro 
(Figure 5.2). We found that medial thickness increased with age 38%, from 61.9 +/- 0.9 
)liD to 85.4 +/- 1.4 )liD (p<0.001). This medial thickening with age was accompanied by 
an unexpected 28% decrease in baseline (unstimulated) material stiffness, taken as the 
slope of the quasi-static stress-strain curve at optimal length (80% strain), from 107.6 +/-
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Figure 5.1. Determination of the optimal length for mouse thoracic aorta. (A) 
Increases in stress due to KCl stimulation (15 min) ("active stress") in young (3 month-
old) and old (29 month-old) mouse thoracic aorta from c=0-200% with respect to slack 
length. (B) Active stress as a percentage of total stress. Active stress is a greater 
proportion of the total stress in older aorta about the optimal length. n=3 for both young 
and old mice. *p<0.05, two-tailed, unpaired Student's t-test. Data collected jointly with 
Yuan Gao (Morgan lab, Boston University). 
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Figure 5.2. Wall thickness increases with age while material stiffness decreases with 
age. Clinical measures of "functional" aortic stiffuess, which is influenced by wall 
geometry, increase with age; however, material stiffuess, which is normalized to cross-
sectional area, decreased here. From left to right, n=34, 25, 15, and 18. ***p<0.001 , two-
tailed, unpaired Student's t-test. Data collected jointly with Yuan Gao (Morgan lab, 
Boston University) . 
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2.7 kPa to 77.0 +/- 1.0 kPa (p<0.001). 
Since the several-fold increase in PWV with age is well-documented in both mice 
and humans (Hartley, Taffet et al. 1997; Wang, Halks-Miller et al. 2000; Mattace-Raso, 
van der Cammen et al. 2006; Willum-Hansen, Staessen et al. 2006), we verified our 
observed decrease in material stiffness in the aged aorta with an alternate in vitro method 
employing small-amplitude, high-frequency sinusoidal stretches (see Methods, Section 
2.8.3). Stiffness measured by this cyclic stretching was reduced by 15% in the old mice, 
from 201.9 +/- 3.3 kPa to 172.2 +/- 4.0 kPa (p<0.001). The numbers obtained with this 
method are typically larger than those obtained from stress-strain curves because of the 
frequency-dependent response of biological tissue and because the small stretches 
preserve cross-bridges. Subsequent measurement of material stiffness in this chapter was 
performed with the stress-strain approach, as it is frequently employed in the field to 
study vascular tissue mechanics. 
5.3.3 Active Aortic Stiffening Increases with Differing Dependence on Src 
Signaling and Contractile Filament Activation with Age 
Next we measured the influence of activated smooth muscle cells on aortic 
stiffness using stress-strain curves (Figure 5.3A; see Methods 2.9). The results are 
summarized in Figure 5.3B and C. Phenylephrine prompted comparable stiffening in 
young and old aortas (an increase of ~15 kPa). ML-9 and PP2 had strong inhibitory 
effects on PE-induced increases in young mice as measured from stress-strain curves, 
inhibiting stiffening by about 70-80% (p<0.01-0.05), which is comparable to results 
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Figure 5.3. PE-induced stiffening of aortic smooth muscle cells is affected differently 
in young and old aorta by inhibitors PP2 and ML-9. (A) Left: Sample stress-strain 
traces for imposed stretches (0 to 100% strain, constant loading and unloading with f = 
0.1 Hz) and force response. Right: Stress and strain were calculated from raw traces and 
plotted against each other. The stiffness was examined at optimal length by taking the 
slope of the curve at £=80%. (B) In young aorta, there is strong inhibition of PE-induced 
stiffening with PP2 and ML-9. In old aorta, PP2 is ineffective, suggesting that focal 
adhesion signaling differs between young and old aorta. While ML-9 significantly 
inhibits PE-induced stiffening in old aorta, its effect is much less pronounced than it is in 
young aorta. (C) The same data as in B but grouped by age. n=6 for PE (young or old), 
n=3 for ML-9 or PP2 (young or old). *p<0.05, **p<0.01, ***p<0.001, two-tailed, 
unpaired Student's t-test. Data collected jointly with Yuan Gao (Morgan lab, Boston 
University). 
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obtained previously with cyclic stretching (Figure 3.5). In old mouse aorta, ML-9 
significantly inhibited PE-induced stiffening by 43% (p<0.05), although less so than in 
young mice, but PP2 did not significantly inhibit stiffening. This implies that Src-
mediated regulation of focal adhesion recycling in old mice is somehow mechanistically 
different from in young mice, or that changes in alpha-receptor affinity or expression or 
their downstream effectors (Figure 1.4) may occur with age, either of which could 
adversely affect VSMC regulation of stiffuess in aged mice. 
5.3.4 Agonist-induced Tyrosine Phosphorylation is Decreased with Age 
To further investigate whether focal adhesions are involved in the changes 
observed in aortic stiffuess with age, we performed phosphotyrosine screens of aorta 
homogenates. As seen in Figure 5.4 (and previously in Figure 3.6), PE stimulation 
induces increases in tyrosine phosphorylation in young mouse aorta for bands at 125 and 
120 kDa (p<0.05). However, the PE-induced increases in tyrosine phosphorylation are 
blunted in the aged mice, especially for the bands at 130 and 68 kDa, suggestive of 
changes in FA signaling versus young aorta. As phosphotyrosine levels are low, it is not 
surprising that PP2 has no significant effect on stiffuess, as Src activity is already 
reduced. These screens may reflect impaired agonist-induced growth and remodeling of 
F As in the aged mice. 
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Figure 5.4. PE stimulation in old aorta induces tyrosine phosphorylation to a lesser 
degree than in young aorta. Mean densitometry of phosphotyrosine bands indicated. PE 
induces significant tyrosine phosphorylation of bands at 125 and 120 kDa but not 130 or 
68 kDa. Increases in tyrosine phosphorylation for the 125- and 120-kDa bands are less 
than those for the corresponding bands in young aorta (see Figure 3.6). n=4-7 
experiments, 3 mice per experiment. *p<0.05 vs. unstimulated, two-tailed Student' s t-
test. Data are courtesy of Cynthia Gallant (Morgan lab, Boston University). 
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5.4 Discussion 
The main findings of this study are that Src-mediated (PP2-sensitive), agonist-induced 
focal adhesion signaling is impaired in old mice and that, consequently, there is no effect 
of PP2 on agonist-induced aortic stiffening in old mice. When combined with our 
observation that PE-induced stiffening does not differ in magnitude between young and 
old aorta, the data presented in this chapter appear to contradict the model proposed in 
Chapter 3 (Figure 3.7). In that model, contractile stimulation induces FA remodeling and 
growth via FAK-Src-mediated tyrosine phosphorylation ofF A proteins, which reinforces 
the link between the actin cytoskeleton and the extracellular matrix and thereby facilitates 
aortic tone development and stiffening. There are two possible explanations for this 
ostensible inconsistency. In the first case, the model in Chapter 3 may only hold for 
young aorta without extending to old aorta. If so, the FA is somehow decoupled from 
stiffness with age. In the second case, the model still holds, but we are missing data on a 
key component, possibly FA size. For instance, it is possible that PP2 does not inhibit 
stiffening in old aorta because the FA is already enlarged prior to agonist stimulation. An 
enlarged FA would enable tone and stiffuess development but would be unaffected by 
PP2 because it is not growing further. There is some indirect evidence of increased FA 
size with age in the literature, as one group has shown increased adhesivity and [3 1-
integrin expression in old primate VSMCs (Qiu, Zhu et al. 2010; Zhu, Qiu et al. 2012). In 
either case of the two cases, the outcome is the same -the VSMCs have effectively lost a 
means of regulating stiffuess, which may play a role in aortic stiffening with age. 
Selecting between these competing hypotheses will require characterization ofF A size in 
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young and old aortic dVSMCs (e.g., cell microscopy experiments or Western blots 
probing p1-integrin expression levels, measurements of cortical stiffness of old aorta 
dVSMCs with the magnetic tweezers, and additional Western blots probing relevant 
signaling pathways). The outcomes of such experiments could provide therapeutic 
targets, perhaps designed to restore FA functionality in old aorta and reverse excessive 
stiffening. 
In this study, we observed an increase in medial thickness (38%) and a concurrent 
decrease in baseline material stiffness (28%) of mouse aorta with age. According to the 
Moens-Korteweg equation, pulse wave velocity is directly proportional to the square root 
of both thickness and material stiffness. Plugging our measurements for young and old 
aortas directly into this equation, we find that the increase in thickness essentially offsets 
the effect of the decrease in material stiffness, and pulse wave velocity is unchanged. 
This is seemingly at odds with results obtained in humans and mice in vivo that pulse 
wave velocity increases more than twofold. 
There are some key differences between our system in vitro and the aorta in vivo 
that must be understood to clarify this discrepancy. The first difference is that the 
thickness that we measured for young and old rings is the unloaded thickness, which 
could differ substantially from the thickness of a pressurize vessel. Next, the aorta in vivo 
is sheathed within an adventitial layer that we have removed for these experiments. As 
discussed in the Methods, dissection of the perivascular tissue from the small, delicate 
mouse aorta also strips the adventitia (~20 ~m thick, in comparison to the ~60 ~m thick 
medial layer). The adventitial layer is known to be rich in collagen and may exhibit 
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increased collagen deposition with age (Fleenor, Sindler et al. 2013); thus, it could be 
major source of stiffness in the aged mouse. A third difference is that the aorta in vivo is 
tethered to the surrounding tissues by the perivascular tissue that is removed in our 
preparations. This connective tissue could directly contribute to the stiffness relevant to 
pulse wave velocity. Alternatively, since this anchorage sets the axial strain in vivo to 
about 10-20% in the proximal thoracic aorta (increasing steadily to about 60% in the 
abdominal aorta) (Guo and Kassab 2003) while our apparatus only stretches the tissue 
uniaxially, it could indirectly influence the mechanical behavior of the aortic wall in the 
circumferential direction. 
Another important Issue relates to differences between in vitro experimental 
parameters and their physiologic analogues in vivo. Our measurements in young and old 
aorta rings were made at the same strain, which, while physiologic in young mice, may 
not be equivalent to the circumferential strain experienced by the aorta in the body of an 
old mouse. Measurements of blood pressure and distended aorta dimensions in our young 
and old mice would be necessary to characterize circumferential strains in vivo. Future 
experiments can be designed using that information to apply a more physiologic 
stretching scheme to aortic rings (e.g., 8 Hz stretching to mimic the mouse rate, with the 
same applied distension as in vivo). Another potential confounder is that smooth muscle 
in vivo exhibits some level of basal tone arising from circulating hormones and paracrine 
factors that are essentially absent in vitro. 
Finally, the application of the Moens-Korteweg equation itself may be 
problematic, as it is predicated on simplifying assumptions that do not hold for blood 
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vessels, including isotropy and homogeneity of a thin-walled tube and small, 
isovolumetric changes during wave propagation. Despite our inability at the present to 
fully resolve how our in vitro stiffness measurement relates to PWV in vivo, the 
reductionist approach employed here is still an extremely valuable tool for isolating the 
influence of VSMCs in aortic stiffening, and even more so when considered with the 
results of experiments performed in vivo. This approach is also an important tool for 
identifying potential new therapeutic targets for the treatment of arterial stiffening. 
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Chapter 6 Modifying Vascular Stiffness using Cell-Permeable Peptide Decoys 
6.1 Summary 
The experiments detailed earlier in this thesis point to the focal adhesion of 
dVSMCs in the blood vessel wall as a key regulator of vascular stiffness and potential 
target for the treatment of cardiovascular disease. In this chapter, I will give an overview 
of experiments in which I take the first steps towards developing a cell-permeable peptide 
(CPP) decoy to interfere with protein-protein interactions in the focal adhesion and thus 
reduce stiffness. I review the principles behind construct design and target selection, 
demonstrate a high-throughput adhesion assay for testing candidates using a first 
generation of peptides, and discuss additional validation experiments for future studies. 
6.2 Introduction 
Cell-permeable peptides (CPPs), also commonly referred to as transduction 
peptides or cell-permeant or -penetrating pep tides (Dunican and Doherty 200 1; Gratton, 
Yu et al. 2003; Joliot and Prochiantz 2004; Heitz, Morris et al. 2009), are a group of short 
peptides that act as delivery vectors capable of rapidly transporting cargoes (e.g., 
molecules, peptides, DNA fragments, proteins, liposomes, magnetic nanoparticles) across 
the cell membrane and into the cytoplasm and nucleus (Joliot and Prochiantz 2004; Zorko 
and Langel 2005; Heitz, Morris et al. 2009). The multiple known CPPs are all positively 
charged and amphipathic, and the exact mechanisms by which different CPPs translocate 
into the cell are disputed (Richard, Melikov et al. 2003; Joliot and Prochiantz 2004; 
Zorko and Langel2005; Heitz, Morris et al. 2009). 
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The TAT peptide, derived from the HIV -1 TAT protein transduction domain, has 
been utilized by many groups to import various payloads into assorted cell types (Frankel 
and Pabo 1988; Fawell, Seery et al. 1994; Vives, Brodin et al. 1997; Wadia, Stan et al. 
2004; Richard, Melikov et al. 2005). Previously, our lab has demonstrated the utility of 
TAT in differentiated vascular smooth muscle by using it to ferry actin monomers into 
VSMCs and monitor polymerization (Kim, Leavis et al. 2010). In this chapter, I design 
and test fluorescent TAT -decoy peptide constructs that target and disrupt FA protein-
protein interactions with the goal of altering vascular stiffness. This application of CPPs, 
based on findings discussed in earlier chapters of this thesis, could represent a novel 
means of preventing or reversing of arterial stiffening and cardiovascular disease. 
6.2.1 Decoy Peptide Design Rationale 
In order to properly perturb focal adhesion function to alter stiffness, some 
thought must first be directed towards which protein-protein interactions constitute 
sensible targets. As a first approach, it is convenient to apply a simplification and classify 
focal adhesion proteins as either structural or signaling proteins, although many FA 
proteins possess dual functionality. Under this conceptual framework, the strategy is to 
impede interactions between structural proteins, which contribute directly to the 
mechanical integrity of the focal adhesion (Figure 6.1 ). Disruption of signaling proteins, 
on the contrary, would have indirect effects on cortical stiffness, as well as numerous off-
target secondary effects due to their downstream outcomes. 
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Figure 6.1. Conceptual diagram of cell-permeable peptide decoy mechanism. (1) The 
TAT cell transduction tag guides the CPP across the vascular smooth muscle cell 
membrane into the cell. (2) Inside the cell, the CPP targets a specific protein with a 
structural role within the focal adhesion. (3) By disrupting the protein's normal protein-
protein interactions within the focal adhesion, the CPP weakens the focal adhesion and 
ultimately reduces vascular tissue stiffness. 
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I selected the talin-vinculin interaction as the target for disruption with a first set 
of CPPs. Talin links transmembrane ~1-integrin directly to actin, and it has 11 vinculin 
binding sites (VBSs) (Critchley 2009). Vinculin bound to talin crosslinks talin to 
additional actin, reinforcing the focal adhesion (Mierke 2009). Most of the VBSs on talin 
are cryptic, putatively exposed upon stretch, but three are normally accessible, VBS 1, 
VBS2, and VBS3 (Critchley 2009). After confirming that these three binding sites exhibit 
minimal sequence similarity with other peptides via protein-protein BLAST (NCBI), they 
were selected for peptide synthesis (see Methods 2.11), which requires relatively short 
sequences (<30 residues), and then conjugated to a TAT transduction tag and a FITC tag 
for visualization (Figure 6.2). Constructs containing the scrambled sequences of the three 
VBSs were also synthesized as controls. I hypothesized that these first generation decoy 
constructs (named CPPl, CPP2, and CPP3) but not their scrambled versions, would 
compete with talin for vinculin within the cell, thereby weakening focal adhesions and 
reducing cortical and tissue stiffness. 
6.3 Results 
6.3.1 Screening Peptide Efficacy by Changes to A 7r5 Cell Adhesion to Substrate in 
a High-Throughput Assay 
Internalization of CPPs was confirmed by fluorescence microscopy, which 
demonstrated localization in the periphery of A 7r5 VSMCs. To screen the efficacy of 
candidate peptides, I developed a high-throughput adhesion assay (see Methods 2.12) 
wherein cultured A7r5s are allowed to plate in the presence ofCPP, scrambled peptide, 
118 
B 
Trypsinize. 
,-;---------:'1 Re·plate 
Confluent VSMCs Add CPP 
A 1st Generation CPPs 
TLN VBS1-3 + FITC +TAT 
nt1 \ltiS t lUi, - ORPU.OAAKGLAC.I.VSELLRSJ.Ol'A - COO~ 
lU~ VIS·2 ,_.1, - NSRI(U.S,.VX~T.-.t(.V..(A.<IKC- CO<)t<, 
T\.N V6S·" w._ -Vli<K£liECAAAVSti(V$rh\.MLO - COOt! 
Tlh \~·'.$oolt'"'-t"" ~tt, - LLAPSO.V.U;~~SGPGK - COOH 
Tl"'\'SS·~IJ'nt4"!!:1 »tt. - f'loq.tOS~ThAUW.£~- COOtt 
nuVBS.lScrllmtf.., liH . - r.lo'IY'I:lH~TRElC ... ;.~.a.o . COOH 
Incubate 
1hr 
or CPP Scrambled High Throughput Adhesion Assay 
for CPP Screening 
c 
* 1.8 
.!!1. 1.6 
Qi~ 
1.4 oo 
-o.::: 
<ll c 1.2 
.J:: 0 
.<:::O 
~.9 1.0 
:t::-o 
<1: <ll 0 .8 . . N 
-o= 
<ll <tl 
0 .6 .<:::E u ~ 
<tl 0 
:t::z 0.4 ro~ 
c:: 
::> 0.2 
0 
l COunt Collect Supernatant ~ Unanached 
(Unanached Cells) { Cells 
Remove 
Adherent Cells 
+ 
Count 
~ Unanached 
Cells 
Control (DMSO) Par-4 Scrambled CPP1 Scrambled CPP1 
Figure 6.2. Screening a first generation of cell-permeable peptide decoys designed to 
disrupt the talin-vinculin interaction to reduce vascular stiffness. (A) The amino acid 
sequences for the first generation of CPPs and their scrambled controls. CPPs were 
chemically synthesized courtesy of Dr. Paul Leavis (Boston Biomedical Research 
Institute, Watertown, MA). (B) Cartoon illustration of the high-throughput assay of 
VSMC adhesion, designed to quantify the effect of CPPs on VSMC adhesion, a putative 
surrogate for stiffness. (C) Results of the high-throughput VSMC adhesion assay reveal 
that CPP 1 significantly impedes VSMC adhesion and should be examined for possible 
effects on stiffness. Inset: Fluorescence microscopy illustrates localization of CPP 1 to the 
VSMC periphery. VSMC morphology suggests that CPPl might affect cell adhesion. 
Red: vinculin, a marker of focal adhesions. Green: CPPl. Scale bar: 20 J-Lm. n=3-5. 
*p<0.05 vs. corresponding scrambled peptide; +p<0.05 vs. DMSO control, two-tailed 
Student's t-test. 
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or vehicle for one hour, then separated into adherent and nonadherent cells for counting 
(Figure 6.2). Peptides that have the desired effect on the focal adhesion should disrupt 
cell adhesion, increasing the ratio of unattached to attached cells. Adhesion in this 
preliminary assay serves as a surrogate for stiffness. 
I found CPPl to significantly inhibit cell attachment (p<0.05); thus, this peptide 
merits further consideration in subsequent studies. CPP2 did not have a significant effect 
on adhesion, and CPP3 had solubility problems that confounded the interpretation of its 
effects (data for both CPP2 and CPP3 not shown). 
6.4 Discussion 
The results obtained with CPP 1 are promising and should be followed up with 
additional studies in vitro and, if successful, in vivo. The next step in this progression is 
to treat vascular tissue in tissue baths in vitro with CPP 1 to see whether it affects 
contractility and stiffness. If so, magnetic tweezer experiments on individual VSMCs and 
Western blot examination of signaling pathways should be performed to confirm that the 
CPP has the intended mode of action and desired effects. Finally, if CPP1 passes all of 
these assessments, testing should be scaled up to a mouse model for safety and efficacy 
studies before clinical trials. 
As the probability that CPPl or any other peptide will ultimately make its way to 
the clinic is slight, the next set of peptides should be developed concurrently with the in 
vitro experiments. Other targets and strategies should be considered, but it is important to 
recognize that any approach can easily underestimate the complexity of the adhesome or 
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the context-dependence of interactions between its constituent proteins. Ongoing research 
by our lab into FA signaling in differentiated, contractile VSMCs with aging could be a 
valuable source of relevant targets. 
In light of evidence from Chapter 5 indicating that focal adhesion signaling is 
impaired with age, a new strategy to try could be to augment some aspect of protein-
protein interactions in the focal adhesion rather than to disrupt it. Some hope for success 
with the CPP approach comes from experiments performed by a different group with 
another transduction peptide, penetratin, which was used to deliver caveolin-1 scaffolding 
domain peptide. That construct was shown to both inhibit acetylcholine-induced 
vasodilation and nitric oxide production in tissues ex vivo and to suppress acute 
inflammation and vascular leak with effectiveness comparable to other inhibitors (Bucci, 
Gratton et al. 2000). 
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Chapter 7: Conclusions and Future Directions 
In this work, I present evidence that the focal adhesion of vascular smooth muscle 
cells is a regulator of blood vessel stiffness. I found that agonist-induced contraction of 
aorta increased cortical stiffness and tissue stiffness by activating F AK- and Src-
dependent focal adhesion signaling. Parallel experiments conducted in veins and aged 
aorta suggest a similar role for focal adhesions in these vessels, albeit with some 
differences; thus, I proposed a model in which focal adhesion size increases in response 
to contractile stimulation in order reinforce the connection between the inside and outside 
of the VSMC and allow for adequate stress and stiffness generation in vascular tissue 
(Figure 3.7). 
The mechanical properties of the three tissue types are summarized in Table 7 .1. 
A comparison between young and old aortas is of particular interest and obvious clinical 
relevance. The key observations are that focal adhesion signaling is aberrant in aged aorta 
and that the unstimulated aortic tissue material stiffness decreases with age as measured 
in vitro, seemingly contrary to the well-known increase in pulse wave velocity in vivo 
(Greenwald 2007). Investigations are ongoing in our lab in an attempt to reconcile our in 
vitro material stiffness measurements with pulse wave velocity. Since one hypothesis 
explaining this discrepancy is that the levels of vasoregulatory agents in vivo are not 
matched in vitro, experiments were performed to ascertain the role of the intact 
endothelium in our preparations. Our findings are consistent with other studies that 
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Thoracic Aorta Portal Vein 
Preparation Endothelium Endothelium Endothelium 
Intact Deactivated Denuded 
(300 f!M L-NAME) 
Geometry Rings Rings Strips 
Uniaxial Pulling Circumferential Circumferential Longitudinal 
VSMC Orientation Circumferential Circumferential Longitudinal 
Species Mouse Mouse Ferret 
Age (months) Young Old Young Old Young 
(3) (29) (3) (29) (3) 
Baseline E (kPa) 210 170 210 - 30 
PE-induced AE (kPa) 45 71 205 178 30 
+PP2 12 58 142 151 20 
+ML-9 22 
-
- - 0.5 
+FI-14 12 
- - - -
Table 7.1. Summary of blood vessel biomechanics in vitro. Preparation details and 
stiffness measurements for aorta and portal vein examined in this thesis using high-
frequency, low-amplitude sinusoidal perturbations. PE-induced stiffening was measured 
at 10 min during stimulation. New data in this table - the stiffness of old aorta with 
endothelium intact (see Chapter 5 for corresponding values measured with stress-strain 
curves) and young and old aorta with endothelium deactivated- are provided by Yuan 
Gao (Morgan Lab, Boston University). Dashes indicate data yet to be acquired. All data 
are means of three or more samples. 
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demonstrate diminished vasoregulatory activity of the endothelium with age (Greenwald 
2007). Moreover, they suggest that some level of basal endothelial activity in vivo might 
account for our aortic tissue stiffness measurements. 
In comparison to the arteries, little is known about the mechanisms behind 
changes in the mechanical properties of the venous tree (Wang, Flewitt et al. 2006). I 
found that passive venous stiffness is much less than passive aortic stiffness, that both the 
venous vascular smooth muscle cells and their focal adhesions represent a much greater 
proportion of total activated tissue stiffness than their counterparts in the aorta, and that 
inhibitors differentially affect the stiffness of the two tissue types. Additional experiments 
are necessary in order to fully characterize these differences and their effects on venous 
compliance, venous return, and overall cardiovascular health and function. 
Focal adhesion regulation of agonist-induced stiffening should be further explored 
via cell immunofluorescence and proximity ligation assay (which visualizes co-localized 
proteins within 40 nm of one another) at the cellular level using freshly-isolated cells 
stained for assorted focal adhesion proteins. As documented in Chapter 4, focal adhesions 
in A 7r5s are characteristically larger than their counterparts in dVSMCs; therefore, future 
experiments should be performed in the more physiologically relevant dVSMC. Together 
with differential fractionation and Western blot I immunoprecipitation experiments at the 
tissue level, these studies will provide a more complete description of signaling events 
and focal adhesion protein translocations in response to different contractile stimuli. This 
protein by protein approach may seem somewhat daunting in light of sheer size of the 
adhesome (Zaidel-Bar, Itzkovitz et al. 2007; Geiger and Zaidel-Bar 2012); however, 
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inspiration can continue to be drawn from studies in migrating, cultured cells, so long as 
we remain mindful of the differences between those cells and the contractile dVSMCs 
native to the vessel wall. 
Mechanics experiments at the tissue level should be performed with more 
physiologic stretching protocols to more closely mimic conditions in vivo. Stiffness 
measurements made in the direction perpendicular to the main axis of the smooth muscle 
cells are also important for characterizing vascular mechanical properties, especially in 
the veins where changes in volume are important to function. Isotonic examination of 
venous tissue shortening in vitro could be used to estimate volume changes. Magnetic 
tweezers experiments conducted using probes with sharper tips or using beads of various 
sizes and coatings could help to characterize stiffness at the cellular level over a broader 
range of forces and conditions (Matthews, LaVan et al. 2004). Another potential tool for 
understanding how the focal adhesion regulates force transmission from the smooth 
muscle cell to the matrix is traction force microscopy (TFM) (Pelham and Wang 1997; 
Beningo, Dembo et al. 2001 ). I have demonstrated that A 7r5 cells can be grown on 
polyacrylamide gels on coverslips and that freshly-isolated dVSMCs will adhere to these 
gels, so long as the gels are an appropriate stiffness, 80 k:Pa and 125 k:Pa, respectively 
(data not shown). Such TFM experiments could be designed to examine the effects of 
various agonists and inhibitors on the traction profile of the cell and, in conjunction with 
cellular staining, relate those effects to the focal adhesion profile of the cell. Together, 
these experiments should elucidate more of the details of focal adhesion regulation of 
vascular tone and stiffness. 
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The findings from this thesis, as well as from future efforts, should inform the 
design of new candidate cell-permeable peptides to reduce arterial stiffness and prevent 
or mitigate the effects of cardiovascular disease. My first generation of cell-permeable 
peptides, designed to disrupt focal adhesion function and reduce stiffness, only yielded 
one potential hit as determined by the high-throughput adhesion assay that I developed. 
Despite passing this benchmark, it is uncertain whether follow-up experiments measuring 
this peptide 's effect on vascular tissue stiffness in vitro and, if successful, on aortic 
stiffness in vivo , will yield results. Therefore, it is important to begin development of the 
next generation of peptides concurrent with these follow-up tests of CPPl. One 
suggestion would be to explore the protein-protein interactions between the ~ 1 integrin 
cytoplasmic tail and its focal adhesion binding partners. 
In conclusion, this thesis expands our understanding of cardiovascular 
biomechanics and demonstrates the power of an experimental approach that spans several 
biological length scales. The idea that the focal adhesion may act as a sort of tunable 
tension sensor for VSMCs in the vessel wall could prove valuable for the design of 
various interventions, whether tissue engineered vascular grafts, pharmacological drugs, 
or other therapeutic agents. It could also contribute towards more comprehensive and 
accurate models of vascular mechanics that integrate the multi-scale biology of the vessel 
wall. 
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